Podcasts about MPH

Welcome to the American Railroading Podcast! In this, our first episode of Season 4, our host Don Walsh is our guest. Don takes us on a journey through 2025 and gives us a recap of each of the podcast episodes from Season 3 along with a look behind the scenes and shares his thoughts not heard before on the episodes themselves. Don also discusses audience feedback and his favorite moments from Season 3, after which he gives his thoughts on where the industry is headed in 2026 and some hints on where the podcast is headed in Season 4. Tune in to this episode to gain valuable insights and broaden your understanding of American Railroading! You can find this episode including episode videos and more on the American Railroading Podcast's official website at www.AmericanRailroading.net . Welcome aboard!KEY POINTS: The American Railroading Podcast remains in the Top 10% of all podcasts globally with a 300% increase in downloads in the last year!The STB offers Stakeholder Committees including the Railroad Shipper Transportation Advisor Council, the Rail Energy Transportation Advisory Committee, the National Grain Car Council and the newly created Passenger Rail Advisory Committee.President Trump's proposed plan to improve the economy and reduce inflation is said to be like spokes on a wheel including reducing the cost of energy by increasing production, reducing government spending, reducing regulations and restrictions, reducing taxes and bringing manufacturing back to the U.S.While intermodal railcars make up only 4% of the U.S. national fleet, 48% of all U.S. rail traffic is generally intermodal rail shipments.Using Ai technology, the Duos Technologies - Railcar Inspection Portal (RIP) can inspect railcars at operating speeds from 3 MPH to 125 MPH, and report findings within 60 seconds.Most new tank car builds (at this time) are due to replacement needs as tank cars age out.Today there are approximately 2 million registered railcars in the U.S. national fleet, of which 22% (or 440,000) are tank cars, all of which require HM-216b qualification at regular intervals.Founded in 1838, Galveston, an island port city in Texas, quickly became the major hub for trade and immigration for not only Texas, but the entire southwest United States, and was the home of the first operating railroad in Texas, founded in 1850.The issue with tariffs isn't whether they're good or bad, it's that they keep fluctuating, they're not consistent, which makes it hard for businesses to plan.While there are 6 Class 1 railroads in the U.S. (UP, BNSF, CSX, NS, CN, and CPKC), there are 603 short line railroads.The AAR establishes safety, security and operating standards that provide seamless and safe operations across America's nearly 140,000-mile freight rail network.Don Walsh gives his opinion of the industry outlook for 2026!LINKS MENTIONED:

In today's episode, Neil Iyengar, MD, moderated an OncLive Insights discussion about adverse effect management when using breast cancer therapies targeting the PI3K, AKT, and mTOR pathways. Dr Iyengar is an associate professor in the Department of Hematology and Medical Oncology and co-director of Breast Medical Oncology in the Department of Hematology and Medical Oncology at Emory University School of Medicine; as well as director of Survivorship Services at the Winship Cancer Institute of Emory University in Atlanta, Georgia. He was joined by Heather Moore, CPP, PharmD, a clinical pharmacist practitioner at the Duke Cancer Center Breast Clinic in Durham, North Carolina; and Sarah Donahue, MPH, NP, a nurse practitioner at the University of California San Francisco Health.  In our exclusive discussion, the experts highlighted the importance of early and comprehensive testing (using both tissue and liquid biopsies) for genetic alterations to guide treatment decisions. They also noted strategies for managing diarrhea, including patient education on diet, proactive use of loperamide, and regular monitoring. They also explained that hyperglycemia management should hinge on prophylactic use of metformin or SGLT2 inhibitors, dietary restrictions, and frequent glucose monitoring. Their conversation on rash management included insights about prophylactic antihistamines, patient education on skin care, and involving dermatology for severe cases. Overall, the experts spotlighted the importance of multidisciplinary collaboration and proactive patient education when treating patients with breast cancer.

We have covered the subject of whether to include the decidual (innermost) layer when closing the uterine incision during cesarean section (CS) on at least 2 episodes. The most recent was in September 2025, when we focused on a published (September 2025) systematic review and meta-analysis from the Green Journal. Back then, we compared those new findings to our prior episode from 2023 on the same matter. Well, we are back at it again with the same subject as there is a new EXPERT REVIEW from the AJOG on hysterotomy closure technique which just came out January 2026. What did these authors conclude? There are also some controversial suggestions made by the authors. Listen in for details. 1. Antoine C, Meyer JA, Silverstein J, Buldo-Licciardi J, Lyu C, Timor-Tritsch IE. Endometrium-Free Closure Technique During Cesarean Delivery for Reducing the Risk of Niche Formation and Placenta Accreta Spectrum Disorders. Obstet Gynecol. 2025 Jun 1;145(6):674-682. doi: 10.1097/AOG.0000000000005813. Epub 2025 Jan 9. PMID: 39787602. 2. Gialdini, Celina et al.Evidence-based surgical procedures to optimize caesarean outcomes: an overview of systematic reviews. eClinicalMedicine- Lancet (June 2024), Volume 72, 102632 3. Dahlke, Joshua D. MD; Mendez-Figueroa, Hector MD; Maggio, Lindsay MD, MPH; Sperling, Jeffrey D. MD, MS; Chauhan, Suneet P. MD, Hon DSc; Rouse, Dwight J. MD. The Case for Standardizing Cesarean Delivery Technique: Seeing the Forest for the Trees. Obstetrics & Gynecology 136(5):p 972-980, November 2020. | DOI: 10.1097/AOG.0000000000004120 4. Antoine C, Timor-Tritsch IE, Bujold E, Young BK, Reece EA. Endometrium-free closure technique for hysterotomy incision at cesarean delivery. Am J Obstet Gynecol. 2026 Jan;233(6S):S103-S114. doi: 10.1016/j.ajog.2025.07.009. PMID: 41485813.

Louis The Child returns for another round of #PlaygroundRadio with tunes MPH, googly eyes, MGMT, Passion Pit, Soul Reductions, A$AP Rocky and many more!Playground Radio Intro 00:00:00Feed Me & Crystal Fighters - Love Is All I Got 00:00:56 Myd - Our Home 00:04:59 Sam Gellaitry - NERVOUS 00:08:30 Don Low - FUNK MOTOR 00:11:54 Street Player - Nothing You Can Do 00:13:34 googly eyes - Bruises on the Peach 00:16:17 A$AP Rocky ft. Brent Faiyaz - STAY HERE 4 LIFE 00:19:06 Beat Connection - Another Go Round 00:23:03 KH, Nelly Furtado - Only Human (MPH Remix) 00:27:12 camoufly - go!!!!!! 00:31:14 Yves, PinkPantheress - Soap 00:33:50 Snakehips, Louis The Child - Nobody Else But U 00:36:16 Louis The Child ft. KFlay - It's Strange 00:39:46 Passion Pit - Little Secrets 00:43:52 MGMT - Time to Pretend 00:47:49 Soul Reductions - Got 2 Be Loved 00:51:58 Fcukers - L.U.C.K.Y 00:58:39

Explore the impact of cyberbullying on veterinary professionals in this episode of Vet Watch with host Christopher Lee, DVM, MPH, DACVPM, DACVM (parasitology); Cert: FFC, CFV, RECOVER-ALS and special guest Heidi Pretzel. 

In this podcast, experts Shazia Nakhoda, MD; Shruti Gupta, MD, MPH; and Anitha Varghese, MSN, APRN, AGPCNP-C, discuss prevention and treatment of acute kidney injury in patients receiving high-dose methotrexate.

In today's episode, the discussion features Aditya Bardia, MD, MPH, FASCO. Dr Bardia is a professor in the Department of Medicine in the Division of Hematology/Oncology, the director of Translational Research Integration, and a member of Signal Transduction and Therapeutics at the UCLA Health Jonsson Comprehensive Cancer Center in Los Angeles, California.In the exclusive interview, Dr Bardia discussed the rationale and design of the phase 3 ELEGANT study (NCT06492616), which is evaluating elacestrant (Orserdu) compared with standard endocrine therapy in patients with estrogen receptor–positive, HER2-negative early breast cancer at high risk of disease recurrence.

In this episode of the Holistic Dentistry Podcast, Dr. Sanda Moldovan interviews Dr. Sri Mummaneni, MD, MPH, who discusses the connection between longevity and spirituality. They explore how personal experiences, self-awareness, and daily habits can enhance well-being. Dr. Mumaneni emphasizes the importance of listening to one's body, understanding burnout, and integrating holistic practices into health care. The conversation also touches on the significance of oral health and community support in achieving overall wellness. Want to see more of The Holistic Dentistry Show? Watch our episodes on YouTube! Do you have a mouth- or body-related question for Dr. Sanda? Send her a message on Instagram! Remember, you're not healthy until your mouth is healthy. So take care of it in the most natural way.  Key Takeaways: Longevity and spirituality are interconnected. Personal health journeys can lead to new insights in medicine. Self-awareness is crucial for living your best life. Listening to your body can prevent burnout. Daily habits like breathing and grounding improve well-being. Sunlight exposure is essential for health. Biohacking should support authenticity and spirituality. Oral health reflects overall well-being. Clenching and grinding may indicate deeper issues. Community support enhances health programs. Guest Info Website abundancehealth.com IG : @drsrimd Connect With Us:  AskDrSanda | YouTube BeverlyHillsDentalHealth.com | Instagram  DrSandaMoldovan.com | Instagram  Orasana.com | Instagram

The Steve Gruber Show | The Psyop Exposed: Climate Lies, ICE Chaos, and Global Meddling --- 00:00 - Hour 1 Monologue 16:18 – Dr. Michael Hutchison, inventor of the NeuroGuard+. Dr. Hutchison explains how this innovative mouth guard reduces the risk of concussion by more than 99 percent, with results tested and certified by Michigan State University and Wayne State University. He discusses why concussions remain one of the biggest concerns in sports and how NeuroGuard+ could be a game changer for athletes at every level. Visit neuroguardplus.com. 19:00 – Dudley Brown, President of the National Association for Gun Rights. Brown discusses growing friction between gun rights groups and Trump administration officials following a shooting in Minnesota. He explains where disagreements are emerging and what it could mean for Second Amendment advocacy. 28:00 – Dr. Peter A. McCullough, MD, MPH, Chief Scientific Officer at The Wellness Company. Dr. McCullough explains why Americans should consider stockpiling prescription medications alongside food and water during major emergencies. He also covers must-have prescriptions, first aid kits, and provides updates on flu and COVID trends this winter. Visit twc.health/GRUBER and use promo code GRUBER to save 10%. 38:40 - Hour 2 Monologue 47:04 – Dr. David Maimon, Head of Fraud Insights at Sentilink and known as the “Undercover Professor.” Dr. Maimon exposes a massive dark web crime ring draining hundreds of billions of dollars from the federal government. He explains how cybercriminals operate and why stopping them is increasingly difficult. 57:06 – William J. Watkins, Jr., constitutional law expert, practicing attorney, research fellow at The Independent Institute, and author of The Independent Guide to the Constitution. Watkins explains how the United States is testing the limits of federal power. He discusses constitutional boundaries and the long-term consequences of overreach. 1:15:40 - Hour 2 Monologue 1:34:24 – Rep. Parker Fairbairn, representing Michigan's 107th House District. Fairbairn discusses how mismanagement at MDHHS is threatening federal support for rural healthcare. He explains what's at stake for vulnerable communities across the state. 1:43:16 – Ivey Gruber, President of the Michigan Talk Network. Gruber talks about relentless winter weather, ice accumulation on the Hudson River, and why past climate change predictions have missed the mark. The segment also touches on DOGE efforts to root out waste, fraud, and abuse — and a reminder to stay away from wild animals. --- Visit Steve's website: https://stevegruber.com TikTok: https://www.tiktok.com/@stevegrubershow Truth: https://truthsocial.com/@stevegrubershow Gettr: https://gettr.com/user/stevegruber Facebook: https://www.facebook.com/stevegrubershow Instagram: https://www.instagram.com/stevegrubershow/ Twitter: https://twitter.com/Stevegrubershow Rumble: https://rumble.com/user/TheSteveGruberShow

Clinicians and patients are in a state of prognostic uncertainty when they are unsure about the future course of an illness. By embracing uncertainty while cultivating prognostic awareness, neurologists can serve the critical role of supporting patients and families through the living and dying process. In this episode, Casey Albin, MD, speaks with Robert G. Holloway, MD, MPH, FAAN, author of the article "Managing Prognostic Uncertainty in Neurologic Disease" in the Continuum® December 2025 Neuropalliative Care issue. Dr. Albin is a Continuum® Audio interviewer, associate editor of media engagement, and an assistant professor of neurology and neurosurgery at Emory University School of Medicine in Atlanta, Georgia. Dr. Holloway is the Edward and Alma Vollertsen Rykenboer Chair and a professor of neurology in the department of neurology at the University of Rochester School of Medicine and Dentistry in Rochester, New York. Additional Resources Read the article: Managing Prognostic Uncertainty in Neurologic Disease Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @caseyalbin Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Albin: Hello, this is Dr Casey Albin. Today I'm interviewing Dr Bob Holloway about his article on managing prognostic uncertainty in neurologic disease, which appears in the December 2025 Continuum issue on neuropalliative care. Welcome to the podcast, and please introduce yourself to our audience. Dr Holloway: Hi, Casey, and thank you. Again, my name is Bob Holloway. I'm a clinician and neurologist up in Rochester, New York, and I've been doing both neurology and palliative care for many years. Dr Albin: Well, that's fantastic. And I really wanted to emphasize how much I really enjoyed reading this article. I know that we're going to get into some of the pearls that you offer, but I really want to tell the listeners, like, this is a great one to read because not only does it have sort of a philosophical take, but you also really provide some pragmatic tips of how we can help our patients manage this prognostic uncertainty. But maybe just tell us a little bit, what is prognostic uncertainty? Dr Holloway: Yes, thank you. Well, I think everyone has a sense of what prognostic uncertainty is. And it's just the uncertain futures that we as clinicians and our patients face. And I would just say that a way to summarize it is just, how do we manage the "not yet" of neurologic illness? Dr Albin: I love that. In neurologic illness, there is so much "not yet" and there are so many unknowns. And what I thought was really helpful about your article is you kind of give us three buckets in which we can think about the different types of uncertainty our patients are facing. What are those? Dr Holloway: This is, I think, an area that really is of interest to me, thinking about how to organize the prognostic "not yet" or that landscape. And one way I've tried to simplify it is to think about it as data-centered. And that's the world that we mostly live in as neurologists. That's the probability distributions. We also have kind of system-level uncertainties, and that's the uncertainties that our health system affords for our patients. And then we have, also, the patient-centered uncertainties and the uncertainties that those two prior categories cause for our patients. And that's a big uncertainty that we often don't address. Dr Albin: In reading the article, I was really struck by, we spend a lot of time thinking about data uncertainty. Can we get population-based research? Can we sort of look at prognostication scoring? I live in the ICU, and so we think a lot about these, like, scoring metrics and putting patients into buckets and helping us derive their care based on where their severity index is. And I'm sure that is true in many of the divisions of neurology. But what I did not really appreciate---and I thought you did a really fantastic job of kind of drawing our attention to---is there's a lot of system-centered uncertainty. Can you give us a little bit of examples, like, what is system-based uncertainty? Dr Holloway: I think system-level uncertainties just encompass the practical information gaps that may arise during our healthcare encounter. And a lot of, I think, the uncertainty that our patients face and families, they actually describe it as they feel captive by the uncertainty. And it's just the unknowns, not just what affords from the actual information about the disease and its prognosis in the future, but actually the level of the system, like, who's going to take care of them? How do you manage arranging for nurses to come into the home or all those practical-level uncertainties that the system provides that sometimes we don't do a good job of road-mapping for patients. Dr Albin: Absolutely. Because I feel like we have a little bit of a gap in that often as physicians. Like, the family asks, what will hospice at home look like? Well, you know, that's a question for case management. I think they'll come in and they'll tell you. But it strikes me that that's a real gap of my being able to walk patients through. Will they get home health care? Will they have transportation set up? Will there be a nurse who comes in to check? How often are they available? What's the cost going to be? All of these practical aspects of dealing with an illness that are beyond sort of our scope of knowledge, but probably have a huge practical impact to the patient. Dr Holloway: Without question, every encounter patients wonder about, that kind of future wish landscape that we- all our future-oriented desires and hopes. And so much of that is the practical aspects of our health system, which is often fragmented, kind of unknown, uncertain. And that's a huge source of uncertainty for our patients and families. And then that leads to many other uncertainties that we need to address. Dr Albin: Absolutely. I think another one that we, again, maybe don't spend quite as much time thinking about is this patient-level uncertainty. What's going on there? Dr Holloway: Yeah. So, I think patient-level uncertainty is that uncertainty that they experience when confronted with the two other types of uncertainty: the actual data-centered uncertainty and the system-level uncertainty. And that's that, kind of, very huge kind of uncertainty about what it means for them and their family and their future futures. And that's a source of huge stress and anxiety, and often frankly bordering on dread and fear for our patients and families. That actually gets into very levels of uncertainty that I would call maybe over even in the existential realm. Patient-level uncertainty in the actual existential questions or the fear and the dread or the kind of just unnerving aspect of it is actually even more important to patients than the scientific or data-centered uncertainty that we focus most of our attention on. Dr Albin: Yeah, I think this is, to me, was getting towards that, like, what does the patient care about and how are they coping with what is in many times a really dramatic shift in their life expectancy or morbidity expectations and this sort of radical renegotiation about what it means to have a neurologic illness? And how does that shift their thinking about who they are and their priorities in the world? Is that right? Dr Holloway: One thousand percent, and in fact, I will say---and I think is one of the main take home messages is that, you know, managing prognostic certainty is not an end in itself. It really is to help patients and families adaptively cope to their new and often harsh new reality, that we could help them adapt to their new normal. I think that is one of our main tasks as neurologists in our care teams is to help patients find and ultimately maybe achieve existential or spiritual or well-being even in their new health states. You know, that you certainly often see in the intensive care unit, but we often always see in the outpatient realm as well, and all our other diseases. Dr Albin: I think that's really hard to do. I think those conversations are incredibly difficult and trying to navigate where patients want to be, what would bring meaning, what would bring value. I think many of us struggle to have these pretty real and intense conversations with families about what really is important. And one of the things I really liked about this article is you kind of walk us through some steps that we as clinicians can take to get a little bit more comfortable. Maybe just walk us through, what are some of the things that you have found most helpful in trying to get families and patients to open up about what brings them meaning? How are they navigating this new, really uncertain time in their life? Dr Holloway: Yeah, so I do kind of have a ten-point recommendations of how to help cultivate a more integrated awareness of an uncertain future. I mean, I think the most important thing is actually just recognizing that embracing uncertainty as an amazingly remarkable cognitive tool. I mean, let's face it, uncertainty, when it happens with neurologic illness and disease, is often fearful. It's scary. It kind of changes our world. But on the flip side of it, it's a remarkable cognitive tool that actually can help us find new ways and new paths and new creativity. And I think we can use that kind of opposites to help our patients find new meaning in very difficult situations. So, thinking about uncertainty, kind of being courageous, leaning into it and recognizing that it does create anxieties and fear, but it also can kind of help create new solutions and new ideas to help people navigate. Dr Albin: I was hoping that maybe you could give us an example of, like, how would you do that? If a patient comes in and they're dealing with, you know, a new diagnosis and they're navigating this new uncertainty, what are some of the things that you ask to help them reframe that, to kind of take some of the good about that uncertainty? How do you navigate that? Dr Holloway: One of the other recommendations is actually just resetting the timeline and expectations for these conversations. That it shouldn't be expected that patients should accept their harsh new reality immediately, that it takes time in a trusted environment. And that there's this, like, oscillating nature of hopes and fears and dread, and you've just got to work with them over time. And with time, and once you understand who the patient and family are and understand where they find meaning and where they find, actually, joy in their life, or what actually brings them meaning, you can start recasting their futures into credible narratives in their kind of future landscape in ways that I think can help them enter into their new realities within the, you know, framework of disease management that you can offer them within your healthcare team or your healthcare system or wherever you are in the world and the available resources that you have to offer patients and families. Dr Albin: So, this sounds like a lot to me like active listening and really trying to get to know what is important to the family, what is important to the patient. And I guess probably just creating that space even in that busy clinical environment. Do I have that right? Dr Holloway: You can absolutely do that, right. You know, and honestly, active listening, we are challenged in our busy healthcare system to do this, but I think with the right listening skills and the appropriate ways of paying attention, you can definitely illuminate these possible, kind of future-oriented worlds for patients and help them navigate those new terrains with them. Frankly, I think that's a real new space for us in neurology. We don't think about and train how to create credible narratives for patients and families. We do it on the fly, but I think there's so much more work to do. How do you actually keep, you know, that best-case, worst-case, most likely credible narratives for patients that can help them adapt to their new realities and support them on their new journeys? Dr Albin: I love that best-case, worst-case, most likely case. I find that framework really helpful. But you talk in your article, it's not just about using that best case or worst case or most likely, but it's actually building some forecasting into that and having some real data to kind of support what you're saying. And there's a lot of growth towards actually becoming good as a medical forecaster. Can you describe a little bit, what did you mean by that? Dr Holloway: You're absolutely right. I think, actually, one of the skillsets of becoming and managing prognostic uncertainty is actually becoming a skilled medical forecaster. And it's a really tall order. So, we've got to be both good medical forecasters as well as helping patients adaptively cope to their new reality. But the good medical forecasting is actually now going more quantitative in thinking about the data that's available to help think about the important outcomes for patients and families and then predicting what their probabilities are so you can shape those futures around. So, yes, we do have to have an open mindset. We do have to actually look at the data that's available and actually think about, what are those long-term probabilities and outcomes? And we can be honest about those and even communicate them with families. But it's a really good skill set to have. Dr Albin: Yeah. This to me was a little bit about, how do you bring in the data knowledge that we try to get over time as we develop our expertise? You're developing not just a reliance on population-based data, but in my experience, I have seen this. And that sort of ability to kind of look at the patient in front of you, think about the big picture, but also a little bit about their unique medical comorbidities or prior life experiences. So, some of that database knowledge, and then bringing in and getting to know what is important to the patient. And so, sort of marrying that data-centric/patient-centric mindset. Dr Holloway: I love it. I guess the other way of saying that, too, is we need to think with precision, but communicate in narratives. And it's okay to gently put more precise estimates on our probability predictions with patients and families, what we think is the most likely case, best and worst case. Because patients and families want us to be more precise. We often shy away from it, but- so, it's okay to think in precisions, but we've got to put those in narratives in the most likely, best-, and worst-case scenarios. And don't be afraid if you think in terms of ninety percents, ten percents, fifty percents; most patients and families don't mind that. And what they're telling us is they actually want to hear that, if you are comfortable talking in those terms. Dr Albin: Yeah, absolutely. And giving a sense of the humility to say, like, this is my best guess based on medical data and my experience, I would say, but again, none of us have a crystal ball. And I do think families, as long as you're sort of couching your expectations into the sort of imperfect, but I'm doing my best, really appreciate that. Dr Holloway: They totally do all the time. Just say, I simply don't know for certain, but these are my best estimates. That's a good way of just phrasing that. Dr Albin: Yeah. So powerful. I don't know for certain. And then I wanted to just kind of close out, because there's this one term that you use that I thought was so interesting. And I wanted you to kind of tell our listeners a little bit about what you mean here, which is that, when you're actively open-minded, you're using this, quote, "dragonfly eyes." What do you mean by that? Dr Holloway: So, the dragonfly eyes, as you know, they can look at three sixty around them and they just, they move in all directions. Being actively open minded, I guess the biggest example I would say is, I don't like the term prognostic discordance, which means that there's a difference of subjective estimates of prognosis between patients and families. Being openly minded is actually embracing the potential information that the family has about prognosis and incorporating that into your estimates. So, I wouldn't say it's discordances, per se; I think being really actively open-minded is taking that all in and utilizing that as, you know what, they know more than you do about the patient and their loved ones, and they may have insights that can inform your best estimates of prognosis. So, the true dragonfly prognosticator actually is one who embraces and doesn't consider it discord, but considers it kind of new, useful information that I just need to weigh in so I can help the family in my best professional way in terms of developing a prognosis, whatever the condition may be. Dr Albin: I can imagine this is just so challenging and something that takes a long time to sort of perfect all of this. I think you say right below that, you need a growth mindset to do this because it is hard, and it's going to take an active participation and an active desire to get better at these conversations with our families. Dr Holloway: One thousand percent. You are so right that it takes time, effort, and not feeling like you're being challenged, but that actually you are including them in your entire body of knowledge, that you're just- it's part of all you're collecting. And even, I was on service last week, and I talked to residents and students about that very issue. It's like take their prognosis. And someone who came in, we thought CJB, very sad, tragic case, but we were thinking about what the future may look like and how do we actually work with the family who had very what we thought was unrealistic expectations. I said, well, no, this is not discordance. This is just useful information that we can take understand where they're coming from and incorporate that into the ways we want to build relationships, build trust, and over time we'll get to a point where we hopefully can work with them and have them have that fully integrated awareness of their future. Dr Albin: Yeah, that's beautiful. It really is this ongoing negotiation that really requires so much listening, understanding, and then obviously information and expertise about the data that we're presenting and the likelihood outcome, recognizing that there's a lot of uncertainty in all of this. Which, you know, again, this is kind of a 360 talk. At every level there is uncertainty, and that's what makes it so hard. Dr Holloway: Yeah, you're absolutely right. And actually, even in the article I kind of used the term radical uncertainty as that, no matter how resolvable all this uncertainty is, there will always still remain that radical element of our existence which we have to actually incorporate and be prepared for. And actually, not only of ourselves, but actually for patients and families and helping manage that. Using narratives and credible narratives and kind of ranges of possibilities is the best way to do that in a personalized way. Dr Albin: Well, this has been a fantastic conversation, and I know that we are running a bit short on time. So, as we wrap up and you think about this topic, are there any key take-home messages that you hope our listeners will walk away with? Dr Holloway: I think one main emphasis is that despite all the successes we feel we have in neurology, is that we all have to recognize that prognostic uncertainty is just going to increase in the future. But this is going to be for several reasons. One is that, just, the illness uncertainty of all of our great therapies are just going to be creating more uncertainty for the future. And precision medicine is paradoxical, and that actually it creates more uncertainty. So, I think we need to be prepared that we have to manage prognostic uncertainty better, because it's definitely going to increase. And two, it's what I said earlier, is that actually managing prognostic uncertainty is not an end to itself. It's actually helping patients and families adapt to their new and sometimes harsh new reality and actually help them to ultimately get to a place where maybe either their condition is neither dreaded, but actually they can accept it as their new reality and actually achieve some sort of existential well-being and existential health. I think that we have a lot more to emphasize in this area. And for far too long, we've focused on the certainty aspect of our field and not enough on the uncertainty in the world of medicine to help our patients and families. Dr Albin: And gosh, isn't there just so much uncertainty? And I think this has been beautiful. So, thank you again for coming and sharing your expertise. Dr Holloway: Thank you very much. It's been a pleasure. Dr Albin: For all of our listeners out there, this is a truly fantastic article, and I would just like to direct you to going to read the cases because not only do the cases offer a little bit of practical advice, but there's one that's actually sort of a philosophical discussion about, what does it mean to be alive and confront death? There's some beautiful artwork that's featured as well. So this is just a really unique article, and I'm excited for our listeners to have a chance to check it out. So again, today I've been interviewing Dr Bob Holloway about his article on managing prognostic uncertainty in neurologic disease, which appears in the December 2025 Continuum issue on neuropalliative care. Be sure to check out Continuum Audio episodes from this and other issues. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

(00:00-38:22) Doug was only able to go about 70 MPH on the way to work this morning. Back up and running St. Louis. Jackson drove himself to work today. Shoveling for the elderly. Did it for Jake. Al in Dadeville is really charging. Playing the poly markets. Sweating out the Arizona BYU game. Chuck Todd and the Revolutionaries in town. Michigan's a wagon but I been saying Arizona. Wagons and buckets. A slow moving zeppelin. Jackson doesn't want to rank the local college teams. it'll cost you a small fortune to get into the Rutgers game. What's the linen sitch?(38:30-50:33) Biff and Larry are on the line. Let's go to Biff. Biff's not there. Larry dropped when we went to Biff so now we got no one. They're both back so let's go with Larry and the wrestling recap. They're not happy with the call in the text inbox. Some breaking news after the break and all hell is gonna break loose.(50:43-1:18:10) Joe Lunardi's latest bracketology is out. Let's get Brad Underwood on for comment. Sellin' the rag. Everyone has to keep winning. Kwame Voyukas IV says he's gonna call in. Let's not go tippin' caps just yet. Phone lines are bone dry. Speaking of love connection, KV4 has called in to clear things up with Jackson. Take it up with KenPom. Talks of giving Jackson a swirly on Friday. Wedgies vs. Swirlys.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This episode is sponsored by Flipping 50 Menopause Fitness Specialist. Become a health & fitness coach who finally speaks midlife women's language. Learn how to design workouts that balance hormones that actually get results for women in menopause. Other Episodes You Might Like: Previous Episode - Why Muscle Growth Feels Harder in Menopause (and What Actually Works) More Like This - Optimizing Hormones Early in Perimenopause Resources: Don't know where to start? Book your Discovery Call with Debra. Leave this session with insight into exactly what to do right now to make small changes, smart decisions about your exercise time and energy. Join the Flipping50 Insiders Facebook Group. Connect with other women navigating menopause fitness and get daily tips and support. Use Flipping 50 Scorecard & Guide to measure what matters with an easy at-home self-assessment test you can do in minutes. Hormones and hot flashes with humor is exactly the kind of conversation women in midlife have been missing—real, honest, and refreshingly human. Let's get straight to what's actually happening in your body when symptoms like hot flashes, poor sleep, mood changes, and fatigue show up. Instead of treating midlife like a breakdown, we reframe it as a biological transition that deserves better information, better support, and better strategies. Get ready for a fun chat about hormones and hot flashes with humor and content you want served in a dish you'll love. My Guest: Dr. Carrie Jones, ND, FABNE, MPH, MSCP is an internationally recognized speaker, consultant, author and educator on the topic of women's health and hormones with over 20 years in the industry. Dubbed the “Queen of Hormones,” Dr. Jones is a Naturopathic Physician who did her 2-year residency focused on women's health and endocrinology. She serves as a consultant and educator for several women's health and lab-focused companies. Questions We Answer in This Episode: Why does humor and sarcasm work so well in hormone education for midlife women? How does a hormone expert personally navigate her own midlife transitions? How should women plan for long-term hormone health based on what we know now? What menopause symptoms are commonly overlooked or mistaken for “just aging”? When is the ideal time to start hormone therapy—and what if that window is missed? Who truly should not use hormone therapy—and what myths still cause fear? What will the next 5–10 years look like for women's hormone and menopause care?

In this bonus episode, Pia Pannaraj, MD, MPH, FAAP, breaks down the CDC's new vaccine recommendations. David Hill, MD, FAAP, and Joanna Parga-Belinkie, MD, FAAP, ask about how the changes differ from the AAP's recommendations and what the possible ramifications are for public health. For resources go to aap.org/podcast.

Why is it still so hard to answer the simple question: "What is public health?" In this timely episode, Dr. Huntley is joined by two voices from different generations of the field to unpack why public health remains misunderstood and why that confusion has real consequences as budgets shrink and systems are dismantled. Emily Edgar, an MPH student in epidemiology, and Dr. Nicole D. Vick, a seasoned public health strategist and workforce advocate, offer grounded, human-centered explanations of public health rooted in collaboration, community, and equity. From One Health examples connecting human, animal, and environmental wellbeing to honest conversations about burnout, bias, and historical harm, this episode moves beyond textbook definitions into language people can actually understand. This conversation is a masterclass in explaining public health through stories that resonate why it matters, who it serves, and what's at stake if we can't clearly articulate our value. If you've ever stumbled trying to explain your work to family, funders, or policymakers, this episode is for you. Resources   ▶️ Join the PHEC Community ▶️ Visit the PHEC Podcast Show Notes   ▶️ DrCHHuntley, Public Health & Epidemiology Consulting  

Omari Richins, MPH of Public Health Careers podcast addresses the pressures faced by graduates as they transition into the public health workforce. He emphasizes the importance of navigating this phase with intention rather than rushing into job applications. Omari encourages listeners to define their personal anchors, choose guiding themes for their career journey, and focus on commitments that shape their actions. He advocates for a sustainable job search strategy and highlights the value of mentorship and support during this critical time.

Featuring perspectives from Dr Angela DeMichele, Dr Komal Jhaveri, Dr Erica Mayer, Dr Hope S Rugo and Dr Seth Wander, including the following topics:  Introduction (0:00) 1985 NCI Consensus Conference on Early Breast Cancer: Sir Richard Peto, FRS (2:01) Current Role of Genomic Assays in Treatment Decision-Making for Localized Hormone Receptor (HR)-Positive Breast Cancer — Dr DeMichele (5:13) Case: A premenopausal woman in her mid 40s with an ER-positive, HER2-negative, node-negative infiltrating ductal carcinoma (IDC) after partial mastectomy/radiation therapy who enrolls in the prospective, observational FLEX study: MammaPrint® low risk — Laurie Matt-Amaral, MD, MPH (15:30) Case: A premenopausal woman in her mid 40s after modified radical mastectomy for T2N0 ER-positive, HER2-negative IDC with an Oncotype DX® Recurrence Score (RS®) of 19 — Swati Vishwanathan, MD Case: A woman in her mid 60s with locally advanced (19 cm) ER-positive, HER2-low (IHC 1+) Stage IIIB mucinous carcinoma breast cancer and an RS of 18 — Alan B Astrow, MD (22:40) Role of CDK4/6 Inhibitors and Other Novel Strategies in Therapy for HR-Positive, HER2-Negative Localized Breast Cancer — Dr Jhaveri (30:18) Case: A woman in her mid 50s with ER-positive, HER2-negative Stage IIB, T2N1 IDC after neoadjuvant dose-dense AC-T, lumpectomy and adjuvant radiation therapy — Eleonora Teplinsky, MD (42:14) Case: A woman in her mid 60s with ER-positive, HER2-negative breast cancer with a surgically removed solitary lung metastasis after 4 years of adjuvant letrozole — Eric Fox, DO (46:32) Evolving Up-Front Treatment Paradigm for HR-Positive, HER2-Negative Metastatic Breast Cancer (mBC) — Dr Rugo (49:45) Case: A woman in her early 80s with Type 2 diabetes, well controlled hypertension and recurrent ER-positive, HER2-negative mBC after 4 years of adjuvant letrozole — Sunil Gandhi, MD (1:02:30) Clinical Utility of Agents Targeting the PI3K/AKT/mTOR Pathway for Patients with Progressive HR-Positive mBC — Dr Mayer (1:06:37) Case: A woman in her late 60s with ER-positive, HER2-low (IHC 1+), PIK3CA-mutant mBC with disease progression after 2 years of adjuvant letrozole — Laila Agrawal, MD (1:20:22) Case: A woman in her early 60s with ER-positive, HER2-low PIK3CA-mutant mBC and disease progression on first-line palbociclib/fulvestrant — Dr Teplinsky (1:26:36) Results from the Global Phase III lidERA Breast Cancer Trial of Giredestrant versus Standard Endocrine Therapy as Adjuvant Treatment for ER-Positive, HER2-Negative Localized Breast Cancer (1:31:48) Current and Future Role of Oral Selective Estrogen Receptor Degraders for Progressive HR-Positive mBC — Dr Wander (1:42:30) Case: A woman in her early 100s with locally advanced ER-positive, HER2-negative breast cancer with disease progression on letrozole, now with an ESR1 mutation — Dr Astrow (1:57:51) CME information and select publications

Nursing achieved self-regulation a century ago – so why not dental hygiene? Your host Matt Crespin explores this with Cindy Gadbury-Amyot and Sylvie Martel, lead authors of the ADHA's newly released white paper on self-regulation. With 97% of Canadian dental hygienists self-regulated, Sylvie shares lessons from a 30-year journey of patience, resilience and coalition-building. Meanwhile, Cindy sounds the alarm on threats like Missouri's Oral Preventive Assistant pilot project – and explains why similar legislation is being introduced across the U.S. This episode tackles the big questions: Who should determine scope of practice? How does regulation by dental boards limit access to care? And what will it take to move the profession forward? Whether you're new to the self-regulation conversation or have been advocating for decades, this is essential listening.Guests: Cynthia C. Gadbury-Amyot, RDH, MS, EdD, FADHA; Sylvie Martel, RDH, DipHE (Andragogy)Host: Matt Crespin, MPH, RDH, FADHAadha.org/WhitePapersadha.org/WorkingForYouhttps://www.adha.org/TakeActionhttps://www.adha.org/advocacy/opa/

This new mini-series on Behind the Knife will delve into the technical aspects of the Operative Standards for Cancer Surgery, developed through the American College of Surgeons Cancer Research Program. This second episode highlights the thyroid cancer operative standard.Hosts:Tracy Wang, MD, MPH, FACS is a Professor of Surgery and Vice-Chair of Strategic and Professional Development at the Medical College of Wisconsin with a clinical focus on endocrine surgical oncology. Vladmir Neychev, MD, PhD is a Professor of Surgery at the University of Central Florida College of Medicine with a clinical focus on endocrine surgical oncology.Jack Sample, MD (@JackWSample) is a General Surgery Resident at Mayo Clinic Rochester.Guests:Elizabeth Grubbs, MD (@EGrubbsMD) is a Professor of Surgical Oncology at MD Anderson where she specializes in endocrine tumors, with expertise in cancer of the thyroid.David Hughes, MD is a Clinical Associate Professor of Surgery at University of Michigan, where he focuses on surgical diseases of the endocrine system, including a particular focus on the diagnosis and management of papillary thyroid cancer.Learning Objectives: Understand key preoperative and intraoperative aspects of the evaluation and treatment of patients with biopsy-proven papillary thyroid carcinoma (PTC) greater than or equal to 1 cm. Define factors that guide decision making regarding the extent of surgical resection (lobectomy versus total thyroidectomy) for PTC.Links to Papers Referenced in this EpisodeOperative Standards for Cancer Surgery, Volume 2: Thyroid, Gastric, Rectum, Esophagus, Melanomahttps://www.facs.org/quality-programs/cancer-programs/cancer-surgery-standards-program/operative-standards-for-cancer-surgery/purchase/Kindle edition:Amazon.com: Operative Standards for Cancer Surgery: Volume 2, Section 1: Thyroid eBook : Program, American College of Surgeons Clinical Research, Katz, Matthew HG: Kindle StoreImpact of Extent of Surgery on Survival for Papillary Thyroid Cancer Patients Younger Than 45 years. https://pubmed.ncbi.nlm.nih.gov/25337927/ Extent of Surgery Affects Survival for Papillary Thyroid Cancer. https://pubmed.ncbi.nlm.nih.gov/17717441/Sponsor Disclaimer: Visit goremedical.com/btkpod to learn more about GORE® SYNECOR Biomaterial, including supporting references and disclaimers for the presented content.  Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. Rx only Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium:General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

"I think you and I would get hosed down trying to walk up that fucking hill."This week's scariest movie is... The Long Walk. This film has everything: Stebbins sneezes, out of context Spotify comments, And dropping duces at 3 MPH. If you love walking off warnings, Three Musketeers math, and foxhole friendships, this episode's for you!Please Subscribe, Rate, and Review The Horror Virgin to help more people discover our community.What did you think of our episode on The Long Walk? Tell us on social media @HorrorVirgin FB/IG, @HorrorVirginPod TwitterUp Next: Tales from the HoodSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

About this episode: The U.S. Food and Drug Administration is responsible for reviewing the safety and effectiveness of vaccines—a job that requires deep scientific understanding as well as thoughtful regulatory judgment. In this episode: Dr. Jesse Goodman, a former top vaccine regulator and chief scientist at the FDA, explains how the agency came to lead the world in vaccine oversight—and shares his concerns for the future. Guests: Dr. Jesse Goodman, MPH, is a professor and the director of Georgetown University's Center on Medical Product Access, Safety and Stewardship. He worked at the FDA from 1998 until 2014, including as chief scientist. Host: Dr. Josh Sharfstein is distinguished professor of the practice in Health Policy and Management, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: How HHS, FDA, and CDC Can Influence U.S. Vaccine Policy—KFF Vaccines 101—Johns Hopkins Bloomberg School of Public Health Recent "Expert Panels" Could Undermine the FDA's Credibility—Public Health On Call (September 2025) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌PublicHealthPod on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Lisa VanHoose & Rebekah Griffith on Why PTs Must Lead, Not WaitLive from Graham Sessions, Jimmy sits down with two of the boldest voices in PT:Dr. Lisa VanHoose, PT, PhD, MPH, Professor & Program Director at the University of Louisiana MonroeDr. Rebekah Griffith, The ED DPT, expert in Emergency Department Physical TherapyTopics covered:Why the PT profession is stuck in a burning buildingSubpar care, imposter syndrome, and employee mindsetsPrimary care PT and the problem with 83-word definitionsWhy marketing isn't enough—you have to BE the changeSpicy Graham Sessions takes about DEI, generational gaps, and leveling up

What do ghrelin, cortisol, insulin, and female sex hormones all have in common? In this episode, you'll discover the fascinating relationship between your emotions, hormones, and eating patterns—and how understanding this connection can open the door to true healing and freedom. Amber Romaniuk is an Emotional Eating, Digestive and Hormone Expert, with 12 years experience helping high achieving women create a level of body confidence, intuition and optimal health through powerful mindset healing, self-care and overcoming self-sabotage with food. Having personally overcome a long battle with emotional eating—including gaining and losing over 1,000 pounds, spending more than $50,000 on binge foods, and dedicating five years to restoring her hormones and digestion—Amber has intimately dismantled the limiting beliefs and patterns that once kept her stuck. Today, she empowers others to experience life-changing breakthroughs and achieve what she calls “Body Freedom™”—the confidence, health, and vitality to create amazing lives. Follow her socials: https://amberapproved.ca/ https://www.instagram.com/amberromaniuk   Additional Resources:

We're shoveling out from the winter storm of apathy and despair this week on Sustainability Now! Your host, Justin Mog, is delighted to welcome back into the studio Dr. Natasha DeJarnett to talk about the next installment of the UofL Envirome Institute's “& Science” series, coming up on Thursday, Feb. 5th, with a focus on History & Science. The event begins with a reception at 5:15 pm, and the panel begins promptly at 6:00 pm. It's taking place at Roots 101 African-American Museum (124 N 1st St). Please join us for the third installment of the “& Science” Forums organized by UofL's Christina Lee Brown Envirome Institute. During History & Science, we will celebrate community heroes and hear from an expert panel on the key intersections of history and science. The panel will discuss historic infrastructure affecting environmental health disparities; examine the policy and legal frameworks that shape local climate and environmental conditions; and encourage widespread participation in strengthening Louisville's environment. Please RSVP at https://www.eventbrite.com/e/history-science-tickets-1979812499481. The evening will feature: Speakers: • Dr. John Chenault (Associate Professor, Director of Anti-Racism Initiatives, UofL) • Ms. Hannah Drake (Cultural Strategist; Co-Executive Director, IDEAS xLab; Co-Founder, (Un)Known Project) • Dr. Swannie Jett (Chief Executive Officer, Park DuValle Community Health Center) • Dr. Lynn Pohl (Archivist, The Filson Historical Society) • The Honorable Attica Scott (Former Kentucky State Representative for District 41; Director of Special Projects, Forward Justice Action Network) • Dr. Monica Unseld (Founder and Executive Director, Until Justice Data Partners) "& Science" Trailblazer Awardee: • Dr. Kevin W. Cosby (Senior Pastor, St. Stephen Baptist Church; President, Simmons College of Kentucky) Also Featuring: • Dr. Natasha DeJarnett (Assistant Professor, Christina Lee Brown Envirome Institute, UofL) • Dr. Ricky L. Jones (Professor and Past Chair, Pan-African Studies; Baldwin-King Scholar-in-Residence, Christina Lee Brown Envirome Institute, UofL) About the Series: The Christina Lee Brown Envirome Institute is hosting this quarterly health forum called “& Science". The third installment of the series will focus on History & Science, featuring leaders from different historical and scientific backgrounds. The “& Science” series provides a community forum for conversations at the intersection of health, the environment & science. Topics explored throughout the first year of the series include communication, faith, history, art & science. Natasha DeJarnett, PhD, MPH, BCES, is the co-founder of the “& Science” series, an Assistant Professor in the School of Medicine, and a researcher with UofL's Envirome Institute (https://louisville.edu/envirome). Dr. DeJarnett's research interests include the cardiovascular health burden of extreme heat exposure, air quality, and environmental health disparities. In addition, Dr. DeJarnett is passionate about environmental health research that informs policies and empowering communities through research engagement. As always, our feature is followed by your community action calendar for the week, so get your calendars out and get ready to take action for sustainability NOW! Sustainability Now! is hosted by Dr. Justin Mog and airs on Forward Radio, 106.5fm, WFMP-LP Louisville, every Monday at 6pm and repeats Tuesdays at 12am and 10am. Find us at https://forwardradio.org The music in this podcast is courtesy of the local band Appalatin and is used by permission. Explore their delightful music at https://appalatin.com

Getting into medical school is often reduced to one thing: the MCAT. But the truth is, that's not what got me accepted.In this episode, I break down what actually got me into medical school and why my MCAT score was not the deciding factor. I walk through the real components of a successful medical school application — including GPA, extracurriculars, clinical experience, leadership, research, and personal narrative — and explain how admissions committees evaluate applicants holistically.I talk honestly about my GPA, my MCAT journey, and the medical school requirements many pre-med students stress about, including whether you need a bachelor's degree, how much grades really matter, and what schools are actuallylooking for beyond numbers. I also read a paragraph directly from my own medical school application essay, breaking down why storytelling, reflection, and authenticity can matter more than a perfect score.If you're a pre-med student, MPH student, career changer, or someone feeling discouraged by MCAT pressure, this episode is for you. Whether your MCAT didn't go as planned, your GPA isn't “perfect,” or you're wondering if medical school is still possible — this conversation is meant to give clarity, reassurance, and real insight into the admissions process.

Climate change is one of the most pressing issues facing humanity – and is not a future problem. Changes to the Earth's climate driven by emission of greenhouse gases have led to glaciers shrinking, plant and animal geographic ranges shifting and historical droughts, wildfires and rainfall. What does all of this have to do with the clinical laboratory?  Subscribe to Editors in Conversation on Apple Podcasts, Android, Spotify, or Email and never miss an episode. Guests: Dr. Joesph Wiencek, Director of Clinical Chemistry and Associate Professor at VUMC Andrea Prinzi, Ph.D., MPH, SM(ASCP), bioMérieux Links:  The foundation for the microbiology laboratory's essential role in diagnostic stewardship: an ASM Laboratory Practices Subcommittee report  Approaches to developing and implementing a molecular diagnostics stewardship program for infectious diseases: an ASM Laboratory Practices Subcommittee report  Guiding antimicrobial stewardship through thoughtful antimicrobial susceptibility testing and reporting strategies: an updated approach in 2023  This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Romney Humphries, Ph.D., D(ABMM).  Visit journals.asm.org/journal/jcm to read articles and/or submit a manuscript. Become an ASM member to receive up to 50% off publishing fees when you publish in JCM or any of the ASM journals. Sign up at asm.org/joinasm.

"The United States does not have a national cancer registry. We have a bunch of state registries. Some of those registries do collaborate and share information, but the issue is the registries that do exist typically do not report cancer by occupation. So, we cannot get our arms around the potential work-relatedness of the health outcome given the current way the state registries collect information. What we're trying to set up, is a way to make what is currently an invisible risk, visible," ONS member Melissa McDiarmid, MD, MPH, DABT, professor of medicine and epidemiology and public health director of the division of occupational and environmental medicine at the University of Maryland School of Medicine in Baltimore, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about the University of Maryland School of Medicine Hazardous Drug Safety Center Exposure Registry. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by January 23, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge in the incidence of hazardous drug exposure and the tracking and reporting of healthcare worker exposures. Episode Notes  Complete this evaluation for free NCPD. University of Maryland School of Medicine Hazardous Drug Safety Center Exposure Registry information sheet ONS Podcast™ episodes: Episode 330: Stay Up to Date on Safe Handling of Hazardous Drugs Episode 308: Hazardous Drugs and Hazardous Waste: Personal, Patient, and Environmental Safety Episode 209: Updates in Chemo PPE and Safe Handling ONS Voice articles: Hazardous Drug Surface Contamination Prevails, Despite More Diligent PPE National Hazardous Drug Exposure Registry Safeguards Oncology Professionals NIOSH Releases Its 2024 List of Hazardous Drugs Safe Handling—We've Come a Long Way, Baby! Strategies to Promote Safe Medication Administration Practices Surfaces in Patient Bathrooms Often Contaminated With HDs, Despite Use of Plastic-Backed Pads ONS books: Safe Handling of Hazardous Drugs (fourth edition) Safe Handling of Hazardous Drugs Quick Guide™ ONS course: Safe Handling Basics Clinical Journal of Oncology Nursing articles: Hazardous Drug Exposure: Case Report Analysis From a Prospective, Multisite Study of Oncology Nurses' Exposure in Ambulatory Settings Personal Protective Equipment Use and Surface Contamination With Antineoplastic Drugs: The Impact of the COVID-19 Pandemic Sequential Wipe Testing for Hazardous Drugs: A Quality Improvement Project The Use of Plastic-Backed Pads to Reduce Hazardous Drug Contamination Oncology Nursing Forum articles: Ensuring Healthcare Worker Safety When Handling Hazardous Drugs Factors Influencing Nurses' Use of Hazardous Drug Safe Handling Precautions Other ONS resources: ONS Safe Handling of Hazardous Drugs Quick Guide Introduction to Safe Handling Huddle Card Safe Handling of Hazardous Drugs Learning Library Hematology/Oncology Pharmacy Association (HOPA) course: Safe Handling of Hazardous Drugs National Institute for Occupational Safety and Health (NIOSH) List of Hazardous Drugs in Healthcare Settings, 2024 To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "We thought that in order to answer some of the unclear questions about health risk, we would set up an exposure registry, in this case, for oncology personnel who handle the drugs. This would then create a cohort that we could ask questions to. For example, we could try to characterize whether there is a cancer excess in this group. Or characterize the reproductive abnormalities in excess that people are experiencing." TS 6:21 "It's sort of counterintuitive that the healthcare industry, whose mission itself is care of the sick, is a high-hazard industry. We typically think about the risk as being from infectious diseases, and certainly we've all lived in our practice lifetime through some examples of that. Even before COVID-19, some of us were doing preparation for Ebola and that sort of thing. So, we're kind of used to that. But the hazards that you kind of grew up with, we've routinized or normalized handling group one, human carcinogens, which a number of these drugs are—it's just something we do every day. Well, it is, but we have to do it with respect and with care every day. And I think sometimes in that routineness of it, we have sort of lost sight of the vigilance that we need to maintain." TS 11:19 "It's very easy in the life cycle of a drug in an organization to do something that doesn't just impact you, but unknowingly, you've contaminated a surface for somebody who comes behind you. Who maybe doesn't have plastic protective equipment on because something that got contaminated shouldn't have been contaminated in the first place. If we could all be thinking of it as more of a team sport, especially in terms of safe handling, that our disposition and drug handling affects not just us and our health, but those of our colleagues." TS 24:47 "For the job history pieces, we ask what year you started, what year you stopped, and we ask about estimations of handling. So we'll be able to come up with either a duration or some kind of metric for the intensity and duration of your handling history, which will then permit us to sort the population who completed the survey into sort of low, medium, high. And we'll see whether the health outcomes that are being reported are influenced by that drug handling history." TS 27:45 "The idea that we aren't exposed to the same therapeutic dose we give to our patients is absolutely true. However, the dosing schedule to them versus us is very different, and we are exposed frequently, if not daily, to very small concentrations. They don't reach a cytotoxic dose necessarily, but we do know from a lot of studies that either ourselves or our colleagues are taking up drug from contaminated work environments. And you've probably seen there is an awful lot of intermediate evidence looking at genotoxic insult in pharmacists and nurses who handle the drugs. So clearly we're showing uptake and we're showing that there are biologically plausible, concerning measures that are taking place in us. So, I think that we need to come back and circle around the idea that we need to have deep respect for the toxicity of these agents." TS 35:03

Send us a textWhat if the best ability as a dad is availability—and the fastest way to build it is with a circle of men who meet you at 5:30 a.m., rain or shine? Today, Casey Jacox sits down with sales leader and father of four, Matt Brownlee, for a conversation that blends vulnerability, practical habits, and a whole lot of heart. We talk about guiding kids through injury and adversity, why gratitude can be a competitive advantage, and how a free, peer-led group like F3 can change your mornings and your mindset.Matt brings candid stories from a home where lights get left on, shoes pile up, and love wins anyway. He shares the values he learned from his teacher mom and service-driven dad: be present, finish what you start, and write more by hand. Those simple habits show up everywhere—from apology notes to kids that mend fences, to thank-you letters that unexpectedly close deals months later. We get honest about patience, the power of saying “I'm sorry,” and how to turn the tense car ride home into a coaching moment that sticks.Youth sports pressure is real, so we tackle the specialization question with clarity and nuance. The answer isn't a one-size-fits-all plan; it's listening. Let kids chase what lights them up, protect recovery, and measure success by effort, attitude, and how they treat people. Along the way, Casey and Matt compare notes on building belief—at home, on the course, and in business. Matt's leap from a 15-year corporate career to founding MPH, a sales leadership and coaching firm, reminds us that “go for it” can be a quiet, steady practice: build playbooks, reinforce skills, write the note, show up tomorrow.If you're craving a conversation that leaves you with concrete tools and renewed resolve—say thank you, apologize quickly, find your crew, and keep going—press play. Then tell us: what habit will you practice this week to lead your family better? Subscribe, share with a dad who needs it, and leave a review to help more parents find the show.Support the showPlease don't forget to leave us a review wherever you consume your podcasts! Please help us get more dads to listen weekly and become the ultimate leader of their homes!

Have you ever felt like no matter how much talk therapy you do, you're still stuck in the same cycles of anxiety, burnout, or chronic fatigue? According to Dr. Aimie Apigian, that's because trauma isn't just a psychological story we tell ourselves—it's a biological reality stored in our cells. In this deep-dive episode, we sit down with Dr. Aimie Apigian, MD, MS, MPH, a double board-certified physician and the leading medical expert on the Biology of Trauma®. Dr. Aimie explains why traditional healing models often miss the mark by focusing only on the mind, while ignoring the physiological "stuckness" of the nervous system. We explore the concept of the "trauma body"—the physical manifestation of past overwhelm—and how our biology actually dictates our emotional and mental capacity. In this episode, we cover: Stress vs. Trauma: Why stress can be growth-promoting, but trauma acts as a biological injury that requires a different roadmap for repair. The 5 Stages of Trauma Response: Moving beyond "fight or flight" to understand the full spectrum: startle, stress, the wall, freeze, and shutdown. The "Functional Freeze" Trap: How many high-achievers are actually living in a state of "high-functioning freeze" and why their "drive" might actually be a survival response. Moving to "Calm Alive": Dr. Aimie's signature framework for shifting the body out of survival mode and into a state of authentic safety and vitality. If you've been told your symptoms are "all in your head" or you've reached a plateau in your healing journey, this conversation will give you the science-backed tools to partner with your body and finally move from surviving to thriving. For more information on Dr. Aimie's book go to: The Biology of Trauma To connect with Dr. Aimee Apigian: Instagram: @draimie LinkedIn: Dr. Aimie Apigian  YouTube: @DrAimeeApigian Website: Biology of Trauma Podcast: Biology of Trauma Podcast Follow us on Instagram: @every.body.talks @jenngiamo @schully Subscribe to our YouTube channel! Don't forget to subscribe to the podcast for free wherever you're listening. Apple Podcasts Spotify Be sure to leave a 5 star rating! It really helps grow the show. If you like the show, telling a friend about it would be amazing!

Alexander Miller, MD, FAAD interviewed by Brad P. Glick, DO, MPH, FAAD

About this episode: Renowned nutritionist Marion Nestle likes the federal recommendation to reduce ultra-processed foods and its emphasis on healthy school meals. But there are other things she finds muddled, contradictory, and incomplete about the nation's new dietary guidelines. In this episode: Nestle talks protein, whole grains, and expanding access to healthy foods. Guests: Marion Nestle, PhD, MPH, is emeritus faculty at New York University. She is the author of the Food Politics blog and the book "What To Eat Now: The Indispensable Guide to Good Food, How to Find It, and Why It Matters". Host: Dr. Josh Sharfstein is distinguished professor of the practice in Health Policy and Management, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: RealFood.gov—U.S. Department of Health and Human Services The MAHA 2025-2030 Dietary Guidelines have arrived: Cheerful, Muddled, Contradictory, Ideological, Retro—Food Politics Canada's Low-Risk Alcohol Guidelines—Public Health On Call (January 2026) The Misinformation Around Seed Oils—Public Health On Call (March 2025) Marion Nestle and Food Politics—Public Health On Call (February 2025) What to Eat Now: The Indispensable Guide to Good Food, How to Find It, and Why It Matters—Food Politics Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌PublicHealthPod on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

In this episode, Andrea Cruz, MD, MPH, FAAP, deputy editor for Pediatrics, offers a rundown of the January issue. David Hill, MD, FAAP, and Joanna Parga-Belinkie, MD, FAAP, also speak with Meg Parker, MD, MPH, FAAP, about promoting human milk and breastfeeding for the very low birth weight infant. For resources go to aap.org/podcast.

Why do so many people know what's healthy—yet struggle to follow through? In this episode of NHA Today, host Dr. Frank Sabatino sits down with Timaree Hagenburger, MPH, RDN, LD/N, also known as The Nutrition Professor, to explore the critical gap between nutrition knowledge and real-life behavior change. With over 20 years of experience in plant-based education, public health nutrition, and community-based programs like WIC, Timaree shares powerful stories that reveal why information alone isn't enough—and what actually helps people succeed long term. Together, they discuss food cravings and withdrawal, taste-bud transformation, cultural food identity, and why community, pleasure, and practical support are essential for sustainable whole-food, plant-based living. In this episode, you'll learn: Why motivation fades after inspiration—and how to prevent it How taste buds and cravings change after removing processed foods Why restriction fails but joy and variety succeed How community support turns short-term change into lifelong habits Real-world plant-based success stories from public health settings NHA Today is the official podcast of the National Health Association, the oldest health organization in the U.S. dedicated to evidence-based, healthful living.

Omari Richins, MPH of Public Health Careers podcast welcomes Nadia Tekkal, an independent public health consultant based in Dubai. Nadia shares her unique journey through five countries, highlighting how her diverse experiences have shaped her understanding of public health. She emphasizes the importance of cultural context in health, noting that health is influenced by more than just access to services; it encompasses the environment and societal norms. Nadia also discusses her transition to freelancing, motivated by a desire for flexibility to balance her professional and personal life, especially as a mother. She reflects on the challenges and rewards of consulting, including the importance of networking and building trust with clients.Check out TPHM Storefront

Board complaints are a source of anxiety for many practitioners, but they don't have to be. In this episode of The Vet Blast Podcast presented by dvm360, host Adam Christman, DVM, MBA, sits down with Beth Venit, VMD, MPH, DACVPM, to demystify the process.From debunking common misconceptions to exploring why complaints are increasing, Venit shares essential insights on what to expect and how to navigate the common pitfalls of the profession.

Apply to be featured at the 2026 Respiratory Innovation Summit. The deadline to apply is Feb. 13.The Respiratory Innovation Summit (RIS) is an event that unites the innovators, investors, clinicians and advocacy groups who are leading the charge to create powerful new treatments for diseases of the lungs and airways. This meeting historically attracts 400+ global leaders representing all facets of the respiratory industry, including representatives from start-ups, business development, venture capital, government, academia and clinical medicine. Among those innovators is Maria Artunduaga, MD, MPH, founder of Samay. In this episode, she talks about her experiences in medicine, why she decided to found her company, and the importance of spaces like RIS for inventors and visionaries like her. Patti Tripathi hosts. 

Interview with Katherine Majzoub Morgan, MD, MPP, author of Primary Care Clinicians Available for New Patient Visits, and Ishani Ganguli, MD, MPH, author of A Different Lens on the Primary Care Workforce Shortage—Who Is Accepting New Patients? Hosted by Eve Rittenberg, MD. Related Content: Primary Care Clinicians Available for New Patient Visits A Different Lens on the Primary Care Workforce Shortage—Who Is Accepting New Patients? Changes in Physician Work Hours and Implications for Workforce Capacity and Work-Life Balance, 2001-2021

Interview with Katherine Majzoub Morgan, MD, MPP, author of Primary Care Clinicians Available for New Patient Visits, and Ishani Ganguli, MD, MPH, author of A Different Lens on the Primary Care Workforce Shortage—Who Is Accepting New Patients? Hosted by Eve Rittenberg, MD. Related Content: Primary Care Clinicians Available for New Patient Visits A Different Lens on the Primary Care Workforce Shortage—Who Is Accepting New Patients? Changes in Physician Work Hours and Implications for Workforce Capacity and Work-Life Balance, 2001-2021

Today I got to chat with Keona Gwinn who I met at Tennessee Day on the Hill about a year ago. Keona is a MPH candidate at Meharry Medical College in Nashville, Tennessee and recently delivered a TEDx talked based on the medical home model. Timeline: 1:00 Who is Keona Gwinn?1:49 Tennessee Disability Day on the Hill 20263: 38 Keona's early years: spina bifida, CHOA, Camp krazy legs4.30 Keona's TEDx talk on the medical home accessibility model5:30 Adaptability Beyond Limits6:30 Keona's Purpose and Calling - Maternal Child Health7:33 Emergency Preparedness 8:20 Graduation and Career Plans9: 00 Conclusion

In this episode, Alexander Salerno, MD, MHA, MPH, founder and CEO of Nirvana Healthcare Management Services, shares how ongoing policy uncertainty around the Affordable Care Act is affecting providers and patients, particularly in underserved communities, and outlines what meaningful reform could look like to improve affordability, access, and accountability in healthcare.

This week we're putting a modern twist on everybody's favorite game: The One Year Garage is visiting the fresh, dewy, barely sentient year of 2026 to see what of its offerings might strike the fancy of the diehard old-car obsessives on our panel. Spoiler alert: there are strongly held opinions, some of which are not the same as yours. Along the way, they also cover Tekashi 6ix9ine; hypercar ignorance; the cost of modern car ownership; when 2014 still means "new"; auto show nostalgia; Fiero dreams; DRS on a "street car"; (good) weird small cars; non-metallic snarkiness; exotic e-bikes; Dakar semis; a far-off Scout fantasy; gigantic vehicles with gobs of power; going solo in a Sterrato; Morgan snarkiness; and a general unease with the new car industry. For those unfamiliar, the rules of One Year Garage are simple: each of our contestants, round-robin-style, pick a vehicle for every one of five categories: Sports Car, Daily Driver, Family Hauler, Truck/4x4, and Wild Card. All picks must be (or will theoretically be) available during the 2026 model year. Once a particular car has been picked, it can't be picked again. Self-doubt is encouraged, and judgment must be passed on others' choices. Arguments about what belongs in a certain category are expected. And the group must accidentally leave out at least one important option, the absence of which must raise the ire of a minimum of two people on Instagram. Enjoy! Mentioned in this episode:3:21 The Chevrolet Corvette ZR1X Does 0-60 MPH in 1.68 Seconds Road & Track16:09  Gordon Murray Automotive T.3318:24  Alpine A11020:28 Porsche 911 GT3 with Touring Package21:13  Porsche 911 GT3 RS24:22 AMG E 53 Hybrid Wagon 26:43  Volkswagen ID.Buzz listings28:54  Acura MDX Type S30:31  Honda Jet Echelon32:17  Modified 2023 Honda Civic Type R33:02  Porsche 911 Carrera GTS35:10  Renault 5 - Fully electric city car37:05  2026 Toyota GR8640:10  Ducati Futa E-Bike44:00  Land Rover Defender D7XR47:11  6k-Mile 2023 Cadillac Escalade-V ESV48:38  Lamborghini Huracán Sterrato50:07  2026 GMC Canyon AT4 & AT4X52:36  Taurus T3 Max (FIA)55:41  Lotus Emira57:16  Ferrari Daytona SP358:37  Ferrari 849 Testarossa59:50  2026 Nissan Z1:01:23  Ferrari 296 GTBGot suggestions for our next guest from the BaT community, One Year Garage episode, or (B)aT the Movies subject? Let us know in the comments below!

The CDC and ACEP both recommend opt-out screening for HIV in most emergency departments, though this practice is far from widespread. Host Peter Lorenz, MD, sits down with Emory University's Emma Sizemore, MD, MPH, to discuss the nuances of implementing an opt-out HIV and HCV screening program in the emergency department.

When your food allergy becomes the reason you have to walk out of your own professional presentation, something is deeply broken. That's exactly what happened to Christina LiPuma, MPH, RDN, CDCES, when she had a severe allergic reaction at a national nutrition conference. The culprit? A mislabeled "curry bowl" and a series of "I don't think so" answers that should never have been good enough. You ask if a dish contains peanuts. "I don't think so," says one staffer. "Pretty sure it doesn't," says another. Minutes later, your throat tingles, your heart races—and you realize what "pretty sure" can cost. This week on Eating at a Meeting Podcast LIVE, I'm talking with Christina—Registered Dietitian, Certified Diabetes Care & Education Specialist, and former Policy Associate at the Center for Science in the Public Interest—about what happens when event dining fails, and how we can make it right. We'll discuss:

Do you ever wonder whether your grocery store cares about whether you have a healthy diet? Every time we shop or read advertisement flyers, food retailers influence our diets through product offerings, pricings, promotions, and of course store design. Think of the candy at the checkout counters. When I walk into my Costco, over on the right there's this wall of all these things they would like me to buy and I'm sure it's all done very intentionally. And so, if we're so influenced by these things, is it in our interest? Today we're going to discuss a report card of sorts for food retailers and the big ones - Walmart, Kroger, Ahold Delhaize USA, which is a very large holding company that has a variety of supermarket chains. And this is all about an index produced by the Access to Nutrition Initiative (ATNi), a global foundation challenging the food industry investors and policy makers to shape a healthier food system. The US Retail Assessment 2025 Report evaluates how these three businesses influence your access to nutritious and affordable foods through their policies, commitments, and actual performance. The Access to Nutrition Initiatives' director of Policy and Communications, Katherine Pittore is here with us to discuss the report's findings. We'll also speak with Eva Greenthal, who oversees the Center for Science in the Public Interest's Federal Food Labeling work.   Interview Transcript Access ATNi's 2025 Assessment Report for the US and other countries here: Retail https://accesstonutrition.org/index/retail-assessment-2025/ Let's start with an introduction to your organizations. This will help ground our listeners in the work that you've done, some of which we've spoken about on our podcast. Kat, let's begin with you and the Access to Nutrition Initiative. Can you tell us a bit about the organization and what work it does? Kat Pittore - Thank you. So, the Access to Nutrition Initiative is a global foundation actively challenging the food industry, investors, and policymakers to shape healthier food systems. We try to collect data and then use it to rank companies. For the most part, we've done companies, the largest food and beverage companies, think about PepsiCo, Coca-Cola, and looking are they committed to proving the healthiness of their product portfolios. Do the companies themselves have policies? For example, maternity leave. And these are the policies that are relevant for their entire workforce. So, from people working in their factories all the way up through their corporate areas. And looking at the largest companies, can these companies increase access to healthier, more nutritious foods. One of the critical questions that we get asked, and I think Kelly, you've had some really interesting guests also talking about can corporations actually do something. Are corporations really the problem? At ATNi, we try to take a nuanced stance on this saying that these corporations produce a huge amount of the food we eat, so they can also be part of the solution. Yes, they are currently part of the problem. And we also really believe that we need more policies. And that's what brings us too into contact with organizations such as Eva's, looking at how can we also improve policies to support these companies to produce healthier foods. The thought was coming to my mind as you were speaking, I was involved in one of the initial meetings as the Access to Nutrition Initiative was being planned. And at that point, I and other people involved in this were thinking, how in the world are these people going to pull this off? Because the idea of monitoring these global behemoth companies where in some cases you need information from the companies that may not reflect favorably on their practices. And not to mention that, but constructing these indices and things like that required a great deal of thought. That initial skepticism about whether this could be done gave way, at least in me, to this admiration for what's been accomplished. So boy, hats off to you and your colleagues for what you've been able to do. And it'll be fun to dive in a little bit deeper as we go further into this podcast. Eva, tell us about your work at CSPI, Center for Science in the Public Interest. Well known organization around the world, especially here in the US and I've long admired its work as well. Tell us about what you're up to. Eva Greenthal - Thank you so much, Kelly, and again, thank you for having me here on the pod. CSPI is a US nonprofit that advocates for evidence-based and community informed policies on nutrition, food safety and health. And we're well known for holding government agencies and corporations to account and empowering consumers with independent, unbiased information to live healthier lives. And our core strategies to achieve this mission include, of course, advocacy where we do things like legislative and regulatory lobbying, litigation and corporate accountability initiatives. We also do policy and research analysis. We have strategic communications such as engagement with the public and news media, and we publish a magazine called Nutrition Action. And we also work in deep partnership with other organizations and in coalitions with other national organizations as well as smaller grassroots organizations across the country. Across all of this, we have a deep commitment to health equity and environmental sustainability that informs all we do. And our ultimate goal is improved health and wellbeing for people in all communities regardless of race, income, education, or social factors. Thanks Eva. I have great admiration for CSPI too. Its work goes back many decades. It's the leading organization advocating on behalf of consumers for a better nutrition system and better health overall. And I greatly admire its work. So, it's really a pleasure to have you here. Kat, let's talk about the US retail assessment. What is it and how did you select Walmart, Kroger, and Ahold Dehaize for the evaluation, and why are retailers so important? Kat - Great, thanks. We have, like I said before, been evaluating the largest food and beverage manufacturers for many years. So, for 13 years we have our global index, that's our bread and butter. And about two years ago we started thinking actually retailers also play a critical role. And that's where everyone interfaces with the food environment. As a consumer, when you go out to actually purchase your food, you end up most of the time in a supermarket, also online presence, et cetera. In the US 70% or more of people buy their food through some type of formal food retail environment. So, we thought we need to look at the retailers. And in this assessment we look at the owned label products, so the store brand, so anything that's branded from the store as its own. We think that's also becoming a much more important role in people's diets. In Europe it's a really critical role. A huge majority of products are owned brand and I think in the US that's increasing. Obviously, they tend to be more affordable, so people are drawn to them. So, we were interested how healthy are these products? And the US retail assessment is part of a larger retail assessment where we look at six different countries trying to look across different income levels. In high income countries, we looked at the US and France, then we looked at South Africa and Indonesia for higher middle income. And then finally we looked at Kenya and the Philippines. So, we tried to get a perspective across the world. And in the US, we picked the three companies aiming to get the largest market share. Walmart itself is 25 to 27% of the market share. I've read an amazing statistic that something like 90% of the US population lives within 25 kilometers of a Walmart. Really, I did not realize it was that large. I grew up in the US but never shopped at Walmart. So, it really does influence the diet of a huge number of Americans. And I think with the Ahold Delhaize, that's also a global conglomerate. They have a lot of supermarkets in the Netherlands where we're based, I think also in Belgium and across many countries. Although one interesting thing we did find with this retail assessment is that a big international chain, they have very different operations and basically are different companies. Because we had thought let's start with the Carrefours like those huge international companies that you find everywhere. But Carrefour France and Carrefour Kenya are basically very different. It was very hard to look at it at that level. And so that's sort of what brought us to retailers. And we're hoping through this assessment that we can reach a very large number of consumers. We estimate between 340 to 370 million consumers who shop at these different modern retail outlets. It's so ambitious what you've accomplished here. What questions did you try to answer and what were the key findings? Kat - We were interested to know how healthy are the products that are being sold at these different retailers. That was one of our critical questions. We look at the number of different products, so the owned brand products, and looked at the healthiness. And actually, this is one of the challenges we faced in the US. One is that there isn't one unified use of one type of nutrient profile model. In other countries in the Netherlands, although it's not mandatory, we have the Nutri Score and most retailers use Nutri Score. And then at least there's one thing that we can use. The US does not have one unified agreement on what type of nutrient profile model to use. So, then we're looking at different ones. Each company has their own proprietary model. That was one challenge we faced. And the other one is that in other countries you have the mandatory that you report everything per hundred grams. So, product X, Y, and Z can all be compared by some comparable thing. Okay? A hundred grams of product X and a hundred grams of product Y. In the US you have serving sizes, which are different for different products and different companies. And then you also have different units, which all of my European colleagues who are trying to do this, they're like, what is this ounces? What are these pounds? In addition to having non-comparable units, it's also non-standardized. These were two key challenges we face in the US. Before you proceed, just let me ask a little bit more about the nutrient profiling. For people that aren't familiar with that term, basically it's a way to score different foods for how good they are for you. As you said, there are different profiling systems used around the world. Some of the food companies have their own. Some of the supermarket companies have their own. And they can be sort of unbiased, evidence-based, derived by scientists who study this kind of thing a lot like the index developed by researchers at Oxford University. Or they can be self-serving, but basically, they're an index that might take away points from a food if it's high in saturated fat, let's say but give it extra points if it has fiber. And that would be an example. And when you add up all the different things that a food might contain, you might come away with a single score. And that might then provide the basis for whether it's given a green light, red light, et cetera, with some sort of a labeling system. But would you like to add anything to that? Kat - I think that's quite accurate in terms of the nutrient profile model. And maybe one other thing to say here. In our retail index, it's the first time we did this, we assess companies in terms of share of their products meeting the Health Star rating and we've used that across all of our indexes. This is the one that's used most commonly in Australia and New Zealand. A Health Star rating goes zero to five stars, and 3.5 or above is considered a healthier product. And we found the average healthiness, the mean Health Star rating, of Walmart products was 2.6. So quite low. Kroger was 2.7 and Food Lion Ahold Delhaize was 2.8. So the average is not meeting the Health Star rating of 3.5 or above. We're hoping that by 2030 we could see 50% of products still, half would be less than that. But we're not there yet. And another thing that we looked at with the retail index that was quite interesting was using markers of UPFs. And this has been a hotly debated discussion within our organization as well. Sort of, how do you define UPF? Can we use NOVA classification? NOVA Classification has obviously people who are very pro NOVA classification, people who also don't like the classification. So, we use one a sort of ranking Popkins et al. developed. A sort of system and where we looked at high salt, fat sugar and then certain non-nutritive sweeteners and additives that have no benefit. So, these aren't things like adding micronutrients to make a product fortified, but these are things like red number seven and colors that have no benefit. And looked at what share of the products that are produced by owned label products are considered ultra processed using this definition. And there we found that 88% of products at Walmart are considered ultra processed. Wow. That's quite shocking. Eighty eight percent. Yeah, 88% of all of their own brand products. Oh, my goodness. Twelve percent are not. And we did find a very high alignment, because that was also a question that we had, of sort of the high salt, fat, sugar and ultra processed. And it's not a direct alignment, because that's always a question too. Can you have a very healthy, ultra processed food? Or are or ultra processed foods by definition unhealthy beyond the high fat, salt, sugar content. And I know you've explored that with others. Don't the retailers just say that they're responding to demand, and so putting pressure on us to change what we sell isn't the real problem here, the real issue. It's to change the demand by the consumers. What do you think of that? Kat - But I mean, people buy what there is. If you went into a grocery store and you couldn't buy these products, you wouldn't buy them. I spent many years working in public health nutrition, and I find this individual narrative very challenging. It's about anything where you start to see the entire population curve shifting towards overweight or obesity, for example. Or same when I used to work more in development context where you had a whole population being stunted. And you would get the same argument - oh no, but these children are just short. They're genetically short. Oh, okay. Yes, some children are genetically short. But when you see 40 or 50% of the population shifting away from the norm, that represents that they're not growing well. So I think it is the retailer's responsibility to make their products healthier and then people will buy them. The other two questions we tried to look at were around promotions. Are our retailers actively promoting unhealthy products in their weekly circulars and flyers? Yes, very much so. We found most of the products that were being promoted are unhealthy. The highest amount that we found promoting healthy was in Food Lion. Walmart only promoted 5% healthy products. The other 95% of the products that they're actively promoting in their own circulars and advertising products are unhealthy products. So, then I would say, well, retailers definitely have a role there. They're choosing to promote these products. And then the other one is cost. And we looked across all six countries and we found that in every country, healthier food baskets are more expensive than less healthier food baskets. So you take these altogether, they're being promoted more, they're cheaper, and they're a huge percentage of what's available. Yes. Then people are going to eat less healthy diets. Right, and promoted not only by the store selling these products, but promoted by the companies that make them. A vast amount of food marketing is going on out there. The vast majority of that is for foods that wouldn't score high on any index. And then you combine that with the fact that the foods are engineered to be so palatable and to drive over consumption. Boy, there are a whole lot of factors that are conspiring in the wrong direction, aren't there. Yeah, it is challenging. And when you look at all the factors, what is your entry point? Yes. Eva, let's talk about CSPI and the work that you and your colleagues are doing in the space. When you come up with an interesting topic in the food area and somebody says, oh, that's pretty important. It's a good likelihood that CSPI has been on it for about 15 years, and that's true here as well. You and your colleagues have been working on these issues and so many others for so many years. But you're very active in advocating for healthier retail environments. Can you highlight what you think are a few key opportunities for making progress? Eva - Absolutely. To start off, I could not agree more with Kat in saying that it really is food companies that have a responsibility for the availability and affordability of healthy options. It's absolutely essential. And the excessive promotion of unhealthy options is what's really undermining people's ability to make healthy choices. Some of the policies that CSPI supports for improving the US retail environment include mandatory front of package nutrition labeling. These are labels that would make it quick and easy for busy shoppers to know which foods are high in added sugar, sodium, or saturated fat, and should therefore be limited in their diets. We also advocate for federal sodium and added sugar reduction targets. These would facilitate overall lower amounts of salt and sugar in the food supply, really putting the onus on companies to offer healthier foods instead of solely relying on shoppers to navigate the toxic food environments and make individual behavior changes. Another one is taxes on sweetened beverages. These would simultaneously nudge people to drink water or buy healthier beverages like flavored seltzers and unsweetened teas, while also raising revenue that can be directed towards important public health initiatives. Another one is healthy checkout policies. These would require retailers to offer only healthier foods and beverages in areas where shoppers stand in line to purchase their groceries. And therefore, reduce exposure to unhealthy food marketing and prevent unhealthy impulse purchases. And then another one is we advocate for online labeling requirements that would ensure consumers have easy access to nutrition, facts, ingredients, and allergen information when they grocery shop online, which unbelievably is currently not always the case. And I can also speak to our advocacy around the creating a uniform definition of healthy, because I know Kat spoke to the challenges in the US context of having different retailers using different systems for identifying healthier products. So the current food labeling landscape in the US is very confusing for the consumer. We have unregulated claims like all natural, competing with carefully regulated claims like organic. We have a very high standard of evidence for making a claim like prevents cold and flu. And then almost no standard of evidence for making a very similar claim like supports immunity. So, when it comes to claims about healthiness, it's really important to have a uniform definition of healthy so that if a product is labeled healthy, consumers can actually trust that it's truly healthy based on evidence backed nutrition standards. And also, so they can understand what that label means. An evidence-based definition of healthy will prevent misleading marketing claims. So, for example, until very recently, there was no limit on the amount of added sugar or refined grain in a product labeled healthy. But recent updates to FDA's official definition of healthy mean that now consumers can trust that any food labeled healthy provides servings from an essential food group like fruit, vegetable, whole grain, dairy, or protein. And doesn't exceed maximum limits on added sugar, sodium, and saturated fat. This new healthy definition is going to be very useful for preventing misleading marketing claims. However, we do think its reach will be limited for helping consumers find and select healthy items mainly because it's a voluntary label. And we know that even among products that are eligible for the healthy claim, very few are using it on their labels. We also know that the diet related chronic disease epidemic in the US is fueled by excess consumption of junk foods, not by insufficient marketing of healthy foods. So, what we really need, as I mentioned before, are mandatory labels that call out high levels of unhealthy nutrients like sodium, added sugar, and saturated fat. Thanks for that overview. What an impressive portfolio of things you and your colleagues are working on. And we could do 10 podcasts on each of the 10 things you mentioned. But let's take one in particular: the front of the package labeling issue. At a time where it seems like there's very little in our country that the Democrats and Republicans can't agree on, the Food and Drug Administration, both previously under the Biden Harris Administration, now under the Trump Vance Administration have identified for a package of labeling as a priority. In fact, the FDA is currently working on a mandatory front of package nutrition label and is creating a final rule around that issue. Kat, from Access to Nutrition Initiative's perspective, why is mandatory front of package labeling important? What's the current situation kind of around the world and what are the retailers and manufacturers doing? Kat - So yes, we definitely stand by the need for mandatory front of package labeling. I think 16 countries globally have front of package labeling mandated, but the rest have voluntary systems. Including in the Netherlands where I live and where Access to Nutrition is based. We use the voluntary Nutri Score and what we've seen across our research is that markets where it's voluntary, it tends to not be applied in all markets. And it tends to be applied disproportionately on healthy products. So if you can choose to put it, you put it all on the ones that are the A or the Nutri Score with the green, and then you don't put it on the really unhealthy products. So, then it also skews consumers. Because like Eva was saying, people are not eating often. Well, they, they're displacing from their diet healthy products with unhealthy products. So that that is a critical challenge. Until you make it mandatory, companies aren't going to do that. And we've seen that with our different global indexes. Companies are not universally using these voluntary regulations across the board. I think that's one critical challenge that we need to address. If you scan the world, there are a variety of different systems being used to provide consumers information on the front of packages. If you could pick one system, tell us what we would actually see on the package. Kat - This is one we've been debating internally, and I saw what CSPI is pushing for, and I think there's growing evidence pushing for warning style labels. These are the ones that say the product is high in like really with a warning, high in fat, high in salt, high in sugar. And there is evidence from countries like Chile where they have introduced this to show that that does drive change. It drives product reformulation. Companies change their products, so they don't have to carry one of the labels. Consumers are aware of it. And they actively try to change their purchasing behaviors to avoid those. And there's less evidence I think interpretive is important. A Nutri Score one where you can see it and it's green. Okay, that's quick. It's easy. There are some challenges that people face with Nutri Score, for example. That Nutri Score compares products among the same category, which people don't realize outside of our niche. Actually, a colleague of mine was telling me - my boyfriend was in the grocery store last week. And he's like picked up some white flour tortillas and they had a Nutri Score D, and then the chips had a Nutri Score B. And he's like, well, surely the tortillas are healthier than the chips. But obviously the chips, the tortilla chips were compared against other salty snacks and the other one was being compared to bread. So, it's like a relatively unhealthy bread compared to a relatively healthy chip. You see this happening even among educated people. I think these labels while well intentioned, they need a good education behind them because they are challenging, and people don't realize that. I think people just see A or green and they think healthy; E is bad, and people don't realize that it's not comparing the same products from these categories. One could take the warning system approach, which tells people how many bad things there are in the foods and flip it over and say, why not just give people information on what's good in a food? Like if a food has vitamins and minerals or protein or fiber, whatever it happens. But you could label it that way and forget labeling the bad things. But of course, the industry would game that system in about two seconds and just throw in some good things to otherwise pretty crappy foods and make the scores look good. So, yeah, it shows why it's so important to be labeling the things that you'd like to see less of. I think that's already happening. You see a lot of foods with micronutrient additions, very sugary breakfast cereals. You see in Asia, a lot of biscuits and cookies that they add micronutrients to. I mean, there's still biscuits and cookies. So Eva, I'd like to get your thoughts on this. So tell us more about the proposed label in the US, what it might look like, and the history about how this got developed. And do you think there's anything else needed to make the label more useful or user-friendly for consumers? Eva - Absolutely. It is a very exciting time to work on food policy in the US, especially with this momentum around front of package labeling. CSPI actually first petitioned calling for front of pack labeling in 2006. And after more than a decade of inaction, industry lobbying, all these countries around the world adopting front of pack labeling systems, but not the US. In 2022 CSPI filed a new petition that specifically called for mandatory interpretive nutrient specific front of package labeling, similar to the nutrient warning labels already required in Mexico, Canada, and as Kat said, around 16 other countries. And in early 2025, FDA finally responded to our petition by issuing a proposal that if finalized would require a nutrition info box on packaged foods. And what the nutrition info box includes is the percent daily value per serving of sodium, added sugar and saturated fat, accompanied by the words high, medium, or low, assessing the amount of each nutrient. This proposal was a very important step forward, but the label could be improved in several ways. First off, instead of a label that is placed on all foods, regardless of their nutrient levels, we strongly recommend that FDA instead adopt labels that would only appear on products that are high in nutrients of concern. A key reason for this is it would better incentivize companies to reduce the amount of salt, sugar, or saturated fat in their product because companies will want to avoid wasting this precious marketing real estate on mandatory nutrition labels. So, for example, they could reduce the amount of sodium in a soup to avoid having a high sodium label on that soup. And also, as you were saying before around the lack of a need to require the positive nutrients on the label, fortunately the FDA proposal didn't, but just to chime in on that, these products are already plastered with claims around their high fiber content, high protein content, vitamin C, this and that. What we really need is a mandatory label that will require companies to tell you what they would otherwise prefer not to. Not the information that they already highlight for marketing purposes. So, in addition to these warning style labels, we also really want FDA to adopt front of package disclosures for foods containing low and no calorie sweeteners. Because this would discourage the industry from reducing sugar just by reformulating with additives that are not recommended for children. So that's a key recommendation that CSPI has made for when FDA finalizes the rule. FDA received thousands and thousands of comments on their labeling proposal and is now tasked with reviewing those comments and issuing a final rule. And although these deadlines are very often missed, so don't necessarily hold your breath, but the government's current agenda says it plans to issue a final rule in May 2026. At CSPI, we are working tirelessly to hold FDA to its commitment of issuing a final regulation. And to ensure that the US front of pack labeling system is number one mandatory and number two, also number one, really, mandatory, and evidence-based so that it really has the best possible chance of improving our diets and our food supply. Well, thank you for the tireless work because it's so important that we get this right. I mean, it's important that we get a system to begin with, even if it's rudimentary. But the better it can be, of course, the more helpful it'll be. And CSPI has been such an important voice in that. Kat, let's talk about some of the things that are happening in developing countries and other parts of the world. So you're part of a multi-country study looking at five additional countries, France, South Africa, Indonesia, the Philippines, and Kenya. And as I understand, the goal is to understand how retail food environments differ across countries at various income levels. Tell us about this, if you would, and what sort of things you're finding. Kat – Yes. So one of our questions was as companies reach market saturation in places like France and the US and the Netherlands, they can't get that many more customers. They already have everyone. So now they're expanding rapidly. And you're seeing a really rapid increase in modern retail purchasing in countries like Indonesia and Kenya. Not to say that in these countries traditional markets are still where most people buy most of their food. But if you look at the graphs at the rate of increase of these modern different retailers also out of home, it's rapidly increasing. And we're really interested to see, okay, given that, are these products also exposing people to less healthy products? Is it displacing traditional diets? And overall, we are seeing that a lot of similar to what you see in other context. In high income countries. Overall healthier products are again, more expensive, and actually the differential is greater in lower income countries. Often because I think also poor people are buying foods not in modern retail environments. This is targeting currently the upper, middle, and higher income consumer groups. But that will change. And we're seeing the same thing around really high percentages of high fat, salt, sugar products. So, looking at how is this really transforming retail environments? At the same time, we have seen some really interesting examples of countries really taking initiative. In Kenya, they've introduced the first Kenyan nutrient profile model. First in Africa. They just introduced that at the end of 2025, and they're trying to introduce also a mandatory front of package warning label similar to what Eva has proposed. This would be these warnings high in fat, salt, and sugar. And that's part of this package that they've suggested. This would also include things around regulations to marketing to children, and that's all being pushed ahead. So, Kenya's doing a lot of work around that. In South Africa, there's been a lot of work on banning marketing to children as well as front of package labeling. I think one of the challenges we've seen there, and this is something... this is a story that I've heard again and again working in the policy space in different countries, is that you have a lot of momentum and initiative by civil society organizations, by concerned consumer groups. And you get all the way to the point where it's about to be passed in legislation and then it just gets kicked into the long grass. Nothing ever happens. It just sits there. I was writing a blog, we looked at Indonesia, so we worked with this organization that is working on doing taxation of sugar sweetened beverages. And that's been on the card since 2016. It actually even reminded me a lot of your story. They've been working on trying to get the sugar sweetened beverage tax in Indonesia passed since 2016. And it gets almost there, but it never gets in the budget. It just never passes. Same with the banning marketing to children in South Africa. This has been being discussed for many years, but it never actually gets passed. And what I've heard from colleagues working in this space is that then industry comes in right before it's about to get passed and says, oh no, but we're going to lose jobs. If you introduce that, then all of the companies that employ people, people will lose their jobs. And modeling studies have shown this isn't true. That overall, the economy will recover, jobs will be found elsewhere. Also, if you factor in the cost to society of treating diabetes from high consumption or sugar sweetened beverages. But it's interesting to see that this repeats again and again of countries get almost over the line. They have this really nice draft initiative and then it just doesn't quite happen. So, I think that that will be really interesting. And I think a bit like what Eva was saying in many of these countries, like with Kenya, are we going to see, start seeing the warning labels. With South Africa, is this regulation banning marketing to children actually going to happen? Are we going to see sugar sweetened beverage taxes written into the 2026 budget in Indonesia? I think very interesting space globally in many of these questions. But I think also a key time to keep the momentum up. It's interesting to hear about the industry script, talking about loss of jobs. Other familiar parts of that script are that consumers will lose choices and their prices will go up. And those things don't seem to happen either in places where these policies take effect. But boy, they're effective at getting these things stomped out. It feels to me like some turning point might be reached where some tipping point where a lot of things will start to happen all at once. But let's hope we're moving in that direction. Kat - The UK as of five days ago, just implemented bans on marketing of unhealthy products to children, changes in retail environment banning promotions of unhealthy products. I do think we are seeing in countries and especially countries with national healthcare systems where the taxpayer has to take on the cost of ill health. We are starting to see these changes coming into effect. I think that's an interesting example and very current. Groundbreaking, absolutely groundbreaking that those things are happening. Let me end by asking you each sort of a big picture question. Kat, you talked about specific goals that you've established about what percentage of products in these retail environments will meet a healthy food standard by a given year. But we're pretty far from that now. So I'd like to ask each of you, are you hopeful we'll get anywhere near those kind of goals. And if you're hopeful, what leads you to feel that way? And Kat, let's start with you and then I'll ask Eva the same thing. Kat - I am hopeful because like you said, there's so much critical momentum happening in so many different countries. And I do find that really interesting. And these are the six countries that we looked at, but also, I know Ghana has recently introduced a or working to introduce a nutrient profile model. You're seeing discussions happening in Asia as well. And a lot of different discussions happening in a lot of different places. All with the same ambition. And I do think with this critical momentum, you will start to break through some of the challenges that we're facing now too. Where you see, for example, like I know this came up with Chile. Like, oh, if you mandate it in this context, then it disadvantages. So like the World Trade Organization came out against it saying it disadvantaged trade, you can't make it mandatory. But if all countries mandate it, then you remove some of those barriers. It's a key challenge in the EU as well. That the Netherlands, for example, can't decide to introduce Nutri Score as a mandatory front of package label because that would disadvantage trade within the European Union. But I think if we hit a critical point, then a lot of the kind of key challenges that we're facing will no longer be there. If the European Union decides to adopt it, then also then you have 27 countries overnight that have to adopt a mandatory front of package label. And as companies have to do this for more and more markets, I think it will become more standardized. You will start seeing it more. I'm hopeful in the amount of momentum that's happening in different places globally. Good. It's nice to hear your optimism on that. So, Eva, what do you think? Eva - So thinking about front of package labeling and the fact that this proposed regulation was put out under the previous presidential administration, the Biden Harris Administration and is now intended to be finalized under the Trump Vance Administration, I think that's a signal of what's really this growing public awareness and bipartisan support for food and nutrition policies in the US. Obviously, the US food industry is incredibly powerful, but with growing public awareness of how multinational food companies are manipulating our diets and making us sick for their own profit, I think there's plenty of opportunity to leverage the power of consumers to fight back against this corporate greed and really take back our health. I'm really happy that you mentioned the bipartisan nature of things that starting to exist now. And it wasn't that long ago where you wouldn't think of people of the political right standing up against the food companies. But now they are, and it's a huge help. And this fact that you have more people from a variety of places on the political spectrum supporting a similar aim to kinda rein in behavior of the food industry and create a healthier food environment. Especially to protect children, leads me to be more optimistic, just like the two of you. I'm glad we can end on that note. Bios Katherine Pittore is the director of Policy and Communications at the Action to Nutrition Initiative. She is responsible for developing a strategy to ensure ATNi's research is translated into better policies. Working collaboratively with alliances and other stakeholders, she aims to identify ways for ATNi's research to support improved policies, for companies, investors and governments, with the aim of creating a more effective playing field enabling markets to deliver more nutritious foods, especially for vulnerable groups in society. Katherine has been working in the field of global nutrition and food systems since 2010. Most recently at Wageningen Centre for Development Innovation (WCDI), where she worked as a nutrition and food security advisor on range projects, mostly in Africa. She also has also worked as a facilitator and trainer, and a specific interest in how to healthfully feed our increasingly urbanizing world. She has also worked for several NGOs including RESULTS UK, as a nutrition advocacy officer, setting up their nutrition advocacy portfolio focusing aimed at increasing aid spending on nutrition with the UK parliament, and Save the Children UK and Save the Children India, working with the humanitarian nutrition team. She has an MSc in Global Public Health from the London School of Hygiene and Tropical Medicine and a BA in Science and Society from Wesleyan University.  Eva Greenthal oversees Center for Science in the Public Interest's federal food labeling work, leveraging the food label as a powerful public health tool to influence consumer and industry behavior. Eva also conducts research and supports CSPI's science-centered approach to advocacy as a member of the Science Department. Prior to joining CSPI, Eva led a pilot evaluation of the nation's first hospital-based food pantry and worked on research initiatives related to alcohol literacy and healthy habits for young children. Before that, Eva served as a Program Coordinator for Let's Go! at Maine Medical Center and as an AmeriCorps VISTA Member at HealthReach Community Health Centers in Waterville, Maine. Eva holds a dual MS/MPH degree in Food Policy and Applied Nutrition from Tufts University and a BA in Environmental Studies from University of Michigan.  

Tune in as Princy N. Kumar, MD, MACP, FRCP, and Charlotte-Paige Rolle, MD, MPH discuss the latest in immune recovery, chronic inflammation, and more in the management of treatment-experienced people living with HIV.Topics covered include:Immunologic nonresponseTheories around soluble gp120 and antibody-dependent cellular cytotoxicityLatest data from BRIGHTE, RECOVER, and moreFuture DirectionsPresenters:Princy N. Kumar, MD, MACP, FRCPProfessor of Medicine and MicrobiologyChief, Division of Infectious Diseases and Tropical MedicineVice Dean for Student AffairsGeorgetown University School of MedicineWashington, DCCharlotte-Paige Rolle, MD, MPHDirector of Research OperationsOrlando Immunology CenterAdjunct Assistant Professor of Global HealthEmory University Rollins School of Public HealthAtlanta, GeorgiaLink to full program: https://bit.ly/4pEenZCGet access to all of our new podcasts by subscribing on Apple Podcasts, Google Podcasts, or Spotify! Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Featuring perspectives from Dr Nancy L Bartlett, Dr John P Leonard, Dr Matthew Matasar, Dr Loretta J Nastoupil and Prof Pier Luigi Zinzani, including the following topics:  Introduction (0:00) Rational Incorporation of Antibody-Drug Conjugates (ADCs) into the Management of Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) — Dr Matasar (1:34) Case: A man in his late 50s who presents with left testicular swelling and abdominal discomfort is diagnosed with ABC-subtype Stage IV DLBCL — Laurie H Sehn, MD, MPH (11:27) Clinical Utility of CD19-Directed Monoclonal Antibodies for DLBCL and Follicular Lymphoma (FL) — Dr Leonard (19:00) Case: A woman in her early 80s with refractory DLBCL receives tafasitamab/lenalidomide — Carla Casulo, MD (32:50) Case: A man in his late 70s with chronic renal disease and relapsed cutaneous DLBCL receives tafasitamab and dose-reduced lenalidomide — Matthew Lunning, DO (35:51) Optimal Use of ADCs in the Treatment of Relapsed/Refractory DLBCL — Prof Zinzani (42:09) Case: A woman in her late 60s with relapsed DLBCL after polatuzumab vedotin with bendamustine/rituximab receives loncastuximab tesirine with partial response and develops a rash — Dr Casulo (57:45) Case: A woman in her early 40s with multiregimen-relapsed GCB-type DLBCL experiences disease progression on loncastuximab tesirine and receives brentuximab vedotin with lenalidomide/rituximab (1:03:07) Bispecific Antibody Therapy for DLBCL — Dr Bartlett (1:08:31) Case: A man in his mid 60s with DLBCL and early relapse on axicabtagene ciloleucel receives glofitamab — Dr Sehn (1:22:33) Case: A man in his late 60s with Type 2 diabetes, congestive heart failure and COPD receives glofitamab monotherapy after glofitamab with gemcitabine/oxaliplatin for relapsed GCB-type double-hit DLBCL — Dr Lunning (1:29:06) Bispecific Antibody Therapy for FL and Other Lymphoma Subtypes — Dr Nastoupil (1:35:34) Case: A woman in her mid 50s with multiregimen-recurrent FL receives mosunetuzumab — Dr Casulo (1:47:01) Case: A man in his late 70s with multiregimen-refractory FL receives mosunetuzumab and achieves an ongoing complete response — Dr Sehn (1:52:23) CME information and select publications

In this episode, Dr. Huntley talks with Montrece McNeill Ransom, JD, MPH, about what it really means to lead in public health during a time of disruption and why this moment may be full of unexpected opportunities. From her path from law school to the CDC to her current work shaping the future public health workforce, Montrece shares powerful insights on belonging, leadership, and why law is one of public health's most underused tools. This conversation will challenge how you think about public health's past, present, and future and just might leave you feeling more hopeful (and fired up) about what comes next.   Resources ▶️ Join the PHEC Community ▶️ Visit the PHEC Podcast Show Notes ▶️ DrCHHuntley, Public Health & Epidemiology Consulting  

This week in track and field, Chris Chavez and Preet Majithia cover:– The World Cross Country Championships showcased impressive performances but faced broadcasting challenges. Preet explains his experience with watching.– Houston's half marathon saw the U.S. men's half marathon list get totally re-written and then a strong run by Taylor Roe to move to No. 2 on the U.S. list.– Zouhair Talbi runs the fourth-fastest marathon by an American but it takes a bit of explaining; Sara Hall went the full distance and continues to impress.– Valencia produced European records by Andreas Almgren and Eilish McColgan.– The bidding for the 2028 U.S. Olympic Marathon Trials is underway and St. Louis is interested.– Preet likes figure skating!– Unsurprisingly, Marvin Bracy-Williams has signed with the Enhanced Games– A look at the other washed-up, has-been runners that are joining the doped Olympics.– Albert Korir was provisionally suspended after testing positive for CERA.– Our way too early picks for the 2028 U.S. Olympic Marathon Trials.____________Mentioned in this episode: Listen: World Cross Country Championships Reactions: Jacob Kiplimo Wins 3rd Straight Title, Agnes Ngetich Dominates + More Highlights____________Hosts: Chris Chavez | ⁠⁠⁠⁠⁠⁠@chris_j_chavez⁠⁠⁠⁠⁠ + Preet Majithia | ⁠⁠@preet_athletics⁠ Produced by: Jasmine Fehr |⁠⁠⁠⁠ ⁠⁠⁠@jasminefehr⁠⁠⁠⁠⁠⁠⁠____________SUPPORT OUR SPONSORSWAHOO: The KICKR RUN responds to you: run faster, it speeds up. Ease back, it slows down. It's called the run-free mode – no buttons, just running that actually feels like running. The Wahoo KICKR RUN turns those long indoor miles into something you actually look forward to. Add in a quiet motor, a buttery smooth belt, and speeds up to 15 MPH, it's the closest thing you can get to an outdoor run without dealing with the ice, wind, or darkness. ⁠⁠⁠⁠Learn more at Wahoofitness.com and unlock a special offer when you use code CITIUS⁠⁠⁠⁠. OLIPOP: Olipop is a better-for-you soda that puts 6-9g of fiber in every single can. This winter, Olipop's holiday cans are back featuring their Yeti Trio. Olipop is a smart, simple way to add more fiber to your day. No recipes, no resolutions, no salads required. Whether you're team Vintage Cola, Crisp Apple, or Ginger Ale, bundle up, pour yourself a can, and sip on some fiber. ⁠⁠⁠⁠Visit DrinkOlipop.com and use code CITIUS25 at checkout to get 25% off your orders.

Fantasy Baseball Live – January 11, 2026 – 3:00pmMicrosoft TeamsPodcastSunday, January 11, 20263:00 PM - 4:30 PMhttps://teams.live.com/meet/9360960458392?p=wO31KjtHU9wOTPVZVJSegment 1 – News and Notes1.The Cubs trade for Edward Cabrera, sending OF Owen Caissie, SS/2B Christian Hernandez, and 2B/3B Edgardo De Leona.I wrote a long note to our Patreon members after the trade was finalized, so I won't reiterate my views. But, what is your take?i.Does Eddie Cabrera go up or down in your rankings or stay the same?ii.I'm assuming Caissie goes up, as he should get a chance to play. What's your take?2.The Cubs also make news, signing Alex Bregman to a long 5-year deal. This one has a lot of ramifications, as it was reported that the Red Sox really wanted to re-sign him.a.What happens to Matt Shaw? It's been widely reported, and I've heard from my contact that the Cubs are not happy with Shaw. I've heard he's difficult to work with, and the Cubs were not happy when he took a day off in September to attend the Charlie Kirk memorial. b.Who plays third for the Red Sox? Do they double down on signing Bo Bichette or go with some combination of Marcelo Mayer and Kristian Campbell3.The Rockies acquire Jake McCarthy on Saturday for RHP Josh Grosza.I know it's the Rockies, but does McCarthy get a jump in value? RosterResource lists him as the starting right fielder.b.It's a bit of a bummer for Dynasty League owners waiting for Zac Veen and Sterlin Thompason to get a shot. It could even gum up the works for Cole Carrigg. Your thoughts?c.I saw Josh Grosz pitch with the Yankees last season in High-A. Fastball sat 93 to 94 MPH and was pretty flat with average secondaries. He does get a new lease with the Diamondbacks, but he's not someone I'd be running out to grab in Dynasty Leagues.4.My draft has slowed to a crawl. I'll share some of my mid-round picks.Segment 2 – Shortstop Rankings for the 2026 Season1.How are you approaching this position for your upcoming drafts?2.We will break down the top 15 to 20 in detail. Then, go through 20 to 30 in less detail. We will end by jumping around the remaining ranked players.3.Which player not in the Top 10 has a chance to emerge there next season?4.Which Top 10 player will not be there next season?5.Give me a couple of sleepers6.Give me one, maybe two guys you are just going to avoid drafting?

Michael A. Cohen, author of the Truth and Consequences newsletter, and Charles Fain Lehman, Fellow at the Manhattan Institute, debate the capture of Nicolas Maduro and whether Marco Rubio is positioning himself as the "Governor General of Latin America." The panel analyzes Tim Walz's exit from the Minnesota governor's race amid a $9 billion pandemic fraud scandal and the controversial appointment of Cea Weaver to New York's housing office. Plus,the debunking of the "Heritage American" myth that only 37–39% of the population meets the pre-1860 ancestry criteria, the New York Times' creative statistics on 8.5 MPH bus speeds, and Larry David's strict January 7th statute of limitations on wishing anyone a "Happy New Year." Produced by Corey Wara Coordinated by Lya Yanne Video and Social Media by Geoff Craig Do you have questions or comments, or just want to say hello? Email us at ⁠⁠⁠⁠thegist@mikepesca.com For full Pesca content and updates, check out our website at https://www.mikepesca.com/⁠ For ad-free content or to become a Pesca Plus subscriber, check out ⁠⁠⁠⁠https://subscribe.mikepesca.com/ For Mike's daily takes on Substack, subscribe to The Gist List https://mikepesca.substack.com/ Follow us on Social Media:⁠⁠⁠⁠ YouTube https://www.youtube.com/channel/UC4_bh0wHgk2YfpKf4rg40_g⁠⁠⁠⁠ Instagram https://www.instagram.com/pescagist/ X https://x.com/pescami TikTok https://www.tiktok.com/@pescagist To advertise on the show, contact ⁠⁠⁠⁠ad-sales@libsyn.com⁠⁠⁠⁠ or visit ⁠⁠⁠⁠https://advertising.libsyn.com/TheGist